1. Neuroscience
Download icon

Cytosolic calcium regulates cytoplasmic accumulation of TDP-43 through Calpain-A and Importin α3

  1. Jeong Hyang Park
  2. Chang Geon Chung
  3. Sung Soon Park
  4. Davin Lee
  5. Kyung Min Kim
  6. Yeonjin Jeong
  7. Eun Seon Kim
  8. Jae Ho Cho
  9. Yu-Mi Jeon
  10. C-K James Shen
  11. Hyung-Jun Kim
  12. Daehee Hwang  Is a corresponding author
  13. Sung Bae Lee  Is a corresponding author
  1. Department of Brain & Cognitive Sciences, DGIST, Republic of Korea
  2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Republic of Korea
  3. School of Biological Sciences, Seoul National University, Republic of Korea
  4. Dementia research group, Korea Brain Research Institute (KBRI), Republic of Korea
  5. Taipei Medical University/Institute of Molecular Biology, Academia Sinica, Taiwan
Research Article
  • Cited 2
  • Views 1,633
  • Annotations
Cite this article as: eLife 2020;9:e60132 doi: 10.7554/eLife.60132

Abstract

Cytoplasmic accumulation of TDP-43 in motor neurons is the most prominent pathological feature in amyotrophic lateral sclerosis (ALS). A feedback cycle between nucleocytoplasmic transport (NCT) defect and TDP-43 aggregation was shown to contribute to accumulation of TDP-43 in the cytoplasm. However, little is known about cellular factors that can control the activity of NCT, thereby affecting TDP-43 accumulation in the cytoplasm. Here, we identified via FRAP and optogenetics cytosolic calcium as a key cellular factor controlling NCT of TDP-43. Dynamic and reversible changes in TDP-43 localization were observed in Drosophila sensory neurons during development. Genetic and immunohistochemical analyses identified the cytosolic calcium-Calpain-A-Importin α3 pathway as a regulatory mechanism underlying NCT of TDP-43. In C9orf72 ALS fly models, upregulation of the pathway activity by increasing cytosolic calcium reduced cytoplasmic accumulation of TDP-43 and mitigated behavioral defects. Together, these results suggest the calcium-Calpain-A-Importin α3 pathway as a potential therapeutic target of ALS.

Introduction

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that mainly affects both upper and lower motor neurons, accompanied by motor symptoms (Taylor et al., 2016). Cytoplasmic accumulation of TDP-43 in motor neurons is the most prominent pathological feature in ALS, which results in impaired protein quality control, mitochondrial dysfunction, and altered stress granule dynamics (Shahheydari et al., 2017; Davis et al., 2018; McDonald et al., 2011). This cytoplasmic accumulation often accompanies depletion of TDP-43 in the nucleus (Neumann et al., 2006), which then results in the loss of its nuclear functions including mRNA splicing (Highley et al., 2014) and the regulation of transcription (Amlie-Wolf et al., 2015). In addition to its occurrence in ALS, the cytoplasmic accumulation of TDP-43 in neurons is also observed in frontotemporal dementia (FTD; about 50% of patients) (Neumann et al., 2006), as well as in Alzheimer’s (Amador-Ortiz et al., 2007), Parkinson’s (Nakashima-Yasuda et al., 2007), and Huntington’s diseases (Schwab et al., 2008), although with lower frequency compared to ALS. These data suggest the importance of proper nucleocytoplasmic localization of TDP-43 for neuronal function.

TDP-43 is known to localize mainly in the nucleus of most neurons examined in non-pathological conditions (Diaper et al., 2013; Neumann et al., 2006; Uchino et al., 2015). Post-translational modifications (PTMs), such as ubiquitination and phosphorylation, and fragmentation of TDP-43 were shown to affect interactions among TDP-43 protein themselves and between TDP-43 and Importins, thereby promoting cytoplasmic accumulation of TDP-43 under pathological conditions including ALS (Neumann et al., 2006; Nonaka et al., 2009). Consistent with these findings, recently, a feedback cycle between nucleocytoplasmic transport (NCT) defect and TDP-43 aggregation was proposed as a model to explain cytoplasmic accumulation of TDP-43 in ALS conditions (Solomon et al., 2018; Gasset-Rosa et al., 2019). In this model, aggregation of TDP-43 in the cytoplasm captures the components (e.g., Importins) of NCT, causing NCT defects and reduced translocation of TDP-43 to the nucleus. These defects increase the amount of TDP-43 in the cytoplasm, which further accelerates cytoplasmic aggregation of TDP-43. Although this model explains the late stages of the disease very well, it remains unclear how this feedback cycle is initiated at the early stages or what predisposes neurons to be vulnerable to this feedback cycle.

Of note, TDP-43 has a property of shuttling between the nucleus and the cytoplasm in neurons under non-pathological conditions, and several factors have been shown to contribute to its NCT. Numerous studies have demonstrated contributions of nuclear transport machineries to NCT of TDP-43, including Importins (Importin α2, α3, and β1) (Nishimura et al., 2010; Solomon et al., 2018), RanGAP (Chou et al., 2018), and components of nuclear pore complexes (Nup62 and Nup54) (Nishimura et al., 2010). The signal sequences for NCT of TDP-43 have been reported: the nuclear localization signal (NLS) of TDP-43 was first identified in both cultured neurons and mouse brains, and its deletion resulted in cytoplasmic accumulation of TDP-43 (Winton et al., 2008). In contrast, deletion of a computationally predicted, leucine-rich nuclear export signal (NES) located at amino acids 239–250 in human TDP-43 (Winton et al., 2008) showed no significant effects on translocation of TDP-43 towards the cytoplasm in neurons (Pinarbasi et al., 2018).

Given that TDP-43 has distinct cytoplasmic functions in addition to its nuclear functions, TDP-43 localization can be dynamically changed (i.e. from nucleus to cytoplasm and vice versa) upon specific cellular demands for its location-specific functions. Although some specific pathological conditions, such as increased stress granule formation (Colombrita et al., 2009) or decreased autophagy (Nguyen et al., 2019), are known to induce cytoplasmic accumulation of TDP-43, it remains elusive whether there exist in neurons certain non-pathological cellular events in which the localization of TDP-43 shifts significantly from the nucleus to cytoplasm and vice versa. In this study, we found that TDP-43 shows cell-type-dependent variation in its localization and can undergo dynamic and reversible changes in its localization during development, one of the major cellular events, in Drosophila sensory neurons. Furthermore, we identify cytosolic calcium as a key cellular factor that controls nucleocytoplasmic localization of TDP-43 and establish the cytosolic calcium-Calpain-A-Importin α3 pathway as a molecular mechanism underlying NCT-mediated cytoplasmic accumulation of TDP-43 in Drosophila neurons.

Results

Proportions of nucleus- and cytoplasm-localized TBPH vary with cell type and developmental stage in Drosophila neurons

Previously, TDP-43 has been reported to be localized mainly to the nucleus in various neurons such as motor neurons in Drosophila (Diaper et al., 2013), mice (Neumann et al., 2006), and humans (Uchino et al., 2015). Recently, however, around 10–20% of neurons in pontine nuclei, thalamus, CA3 region of hippocampus, and orbital cortex showed nuclear depletion and cytoplasmic accumulation of TDP-43 in mice (Termsarasab et al., 2020). Furthermore, it was shown that TDP-43 localized predominantly in the cytoplasm in Drosophila larval class IV dendritic arborization (C4da) sensory neurons (Rumpf et al., 2014) and differentiating mouse myoblasts (Vogler et al., 2018). These pieces of information from multiple studies collectively suggest a hypothesis that TDP-43 is likely to show cell-type-dependent variation in its localization pattern between the nucleus and cytoplasm. To test this hypothesis, we overexpressed Flag-tagged Drosophila TDP-43 (TBPH) in C4da (ppk1a-gal4, membrane marked by HRP staining), motor (D42-gal4, membrane marked by mCD8-RFP), and dopaminergic (DA; TH-gal4, membrane marked by CD4-tdTom) neurons, and in glial cells (repo-gal4, membrane marked by mCD8-RFP) of larvae at 120 hr after egg laying (AEL) using the specified gal4s and membrane markers. We quantitatively measured amounts of TBPH localized in the cytoplasm and the nucleus and then compared cytoplasm-to-nucleus (Cyt/Nuc) ratios in each cell type. The specificity of anti-Flag antibody against TBPH-Flag was confirmed (Figure 1—figure supplement 1A). C4da neurons showed significantly (p<1.0 × 10−4) higher Cyt/Nuc ratios than motor and DA neurons and glial cells by fourfold (Figure 1A and B), consistent with our hypothesis.

Figure 1 with 1 supplement see all
Cell type- and developmental stage-dependent variation in nucleocytoplasmic localization of TBPH.

(A) Subcellular localization of overexpressed TBPH-Flag proteins in sensory (C4da), motor, and dopaminergic (DA) neurons, and in glial cells [Genotype: Sensory (C4da) neurons, +/+;UAS-TBPH-Flag-HA/ppk1a-Gal4, Motor neurons, +/+;UAS-TBPH-Flag-HA/D42-Gal4,UAS-mCD8-RFP, DA neurons, +/+;UAS-TBPH-Flag-HA/TH-Gal4,UAS-CD4-tdTom, Glial cells, +/+;UAS-TBPH-Flag-HA/repo-Gal4,UAS-mCD8-RFP]. DAPI staining was used to mark the nuclei. Merged immunohistochemical images of TBPH proteins (green), plasma membranes (red), and DAPI (blue) are presented at the bottom. Outer and inner dashed lines indicate borders of cell bodies and nuclei, respectively (Scale bars, 5 μm). (B) Quantification of cytoplasmic/nuclear (Cyt/Nuc) ratio of TBPH-Flag proteins in four different cell types described in A. ****p<1.0×10−4 by one-way ANOVA with Tukey’s post-hoc correction; error bars, ± SEM; n = 12 for sensory neurons, n = 24 for motor neurons, n = 7 for DA neurons, n = 28 for glial cells. (C) Subcellular localization of overexpressed TBPH-Flag proteins in C4da neurons at five different developmental time points (120 hr AEL, 0 hr APF, 18 hr APF, 10-day adult, and 40-day adult) [Genotype: +/+;UAS-TBPH-Flag-HA/ppk1a-Gal4,UAS-mCD8-RFP]. Outer and inner dashed lines indicate the borders of cell bodies and nuclei, respectively (scale bars, 5 μm). The intensity profile of fluorescent signals representing TBPH proteins across cell bodies along yellow lines are presented at the bottom. The gray dashed lines mark borders of nuclei (bottom panels). (D) Quantification of Cyt/Nuc ratio of TBPH-Flag proteins at five different developmental time points described in C. ****p<1.0×10−4, ***p=0.0007, **p=0.0042, *p=0.0369 by two-tailed t-test; error bars, ± SEM; n = 6 for 120 hr AEL, n = 9 for 0 hr APF, n = 6 for 18 hr APF, n = 11 for 10-day adult, n = 8 for 40-day adult.

Recently, it has been reported that TDP-43 is localized primarily to the nucleus in uninjured myofibres, but translocated to the cytoplasm in regenerating myofibres following chemical injury in the mouse model (Vogler et al., 2018). This observation suggests a hypothesis that TDP-43 can change its localization during the course of cellular events. We tested this hypothesis in Drosophila neurons during development, one of prominent cellular events in flies. To this end, we overexpressed TBPH in Drosophila C4da neurons and then examined TBPH localization patterns along the development. Interestingly, TBPH changed its localization from the cytoplasm (120 hr AEL) to the nucleus in the pupal stage at 18 hr after puparium formation (APF) (Figure 1C). TBPH was localized to both the cytoplasm and the nucleus in an intermediate stage (0 hr APF) between larva and pupa (Figure 1C), suggesting that TBPH may begin its nuclear entry at this stage. Furthermore, TBPH was localized to both the cytoplasm and the nucleus in an early (10 day; 10d) adult stage and then re-localized mainly to the nucleus in the late (40 day; 40d) adult stage (Figure 1C). Quantitative comparisons revealed that Cyt/Nuc ratios between pairs of consecutive developmental stages (120 hr AEL-0 hr APF, 0-18 hr APF, 18 hr APF-early adult, and early-late adult) were significantly different (Figure 1D). To check whether overexpression might affect this development-dependent variation in Cyt/Nuc ratios, we further examined the localization of endogenous TBPH in C4da neurons at 120 hr AEL and 18 hr APF. Endogenous TBPH showed localization patterns similar to—although less dramatic than—overexpressed TBPH (Figure 1—figure supplement 1B and C). The endogenous TBPH expression level in C4da neurons between the two stages seemed comparable based on the immunostaining data. Taken together, these data suggest that the localization pattern of TBPH between nucleus and cytoplasm in Drosophila neurons varies with cell type and developmental stage.

Cytosolic calcium mediates nucleocytoplasmic translocation of TBPH/TDP-43

Although PTMs of TDP-43 (Neumann et al., 2006; Nonaka et al., 2009) and some pathological conditions such as increased stress granule formation (Colombrita et al., 2009) or decreased autophagy (Nguyen et al., 2019) have been shown to be associated with its nucleocytoplasmic translocation, little is known about cellular factors that govern the nucleocytoplasmic translocation of TDP-43. Along the course of their development, the intracellular calcium levels in neurons are known to undergo dynamic changes; for example, it increases in Drosophila C4da neurons during the pupal period for dendrite pruning (Kanamori et al., 2013), and calcium influx also increases in rat hippocampal neurons during aging (Gant et al., 2006). Together with these previous observations, our data (Figure 1C) suggest a hypothesis that intracellular calcium may act as a cellular factor determining the nucleocytoplasmic translocation of TBPH.

To test this hypothesis, we examined the association of Cyt/Nuc ratios of TBPH with calcium levels in C4da neurons at two developmental stages, larva (120 hr AEL) and pupa (18 hr APF). We measured the calcium level (Figure 2A) using the intensity ratio of genetically encoded calcium indicator (GCaMP) to red fluorescent protein tdTomato (tdTom) as previously described (Daniels et al., 2014). GCaMP/tdTom mean intensity ratio in pupae was significantly increased compared to that in larvae (Figure 2B), suggesting that calcium levels have an inverse relationship with Cyt/Nuc ratios of TBPH. We further examined whether manipulation of intracellular calcium level could alter Cyt/Nuc ratios of TBPH. To this end, given the relatively higher intracellular calcium level in pupae, we decreased intracellular calcium level using previously reported Itprka1091 mutants (Joshi et al., 2004), which have a decreased activity of Inositol (1,4,5)-trisphosphate receptor (Itpr), a major calcium-releasing channel in the endoplasmic reticulum (ER). In the Itprka1091/+ pupae, a significantly (p<0.01) higher amount of TBPH was localized to the cytoplasm compared to the controls, resulting in an increased Cyt/Nuc ratio (Figure 2C and D). Similar results were found using another Itpr mutant (Itprsv35/+) and Itpr RNAi (Figure 2—figure supplement 1A and B). These results are consistent with the previous observation of increased Cyt/Nuc ratio of human TDP-43 in HeLa and SH-SY5Y cells as well as in primary rat cortical neurons upon knockdown of ITPR1 (Kim et al., 2012). Similarly, mutation (RyR16/+) of ryanodine receptor, another major calcium-releasing channel in the ER, led to a similar increase in the Cyt/Nuc ratio of TBPH (Figure 2—figure supplement 1C and D).

Figure 2 with 4 supplements see all
Regulation of nucleocytoplasmic translocation of TBPH by cytoplasmic calcium.

(A) Representative pseudo-colored images representing relative intensity ratios (i.e. calcium level) of GCaMP over tdTom (i.e. overexpressed membrane marker proteins used as a control) in C4da neurons at 120 hr AEL and 18 hr APF [Genotype: +/+;UAS-tdTomato P2A GCaMP5G/ppk1a-Gal4]. (B) Quantification of GCaMP/tdTom mean intensity ratios at 120 hr AEL and 18 hr APF. *p=0.0295 by one-tailed t-test; error bars,± SEM; n = 3 neurons. (C) Subcellular localization of overexpressed TBPH-Flag proteins in C4da neurons of Ctrl or Itprka1091/+ mutants (Itprka1091/+) at 18 hr APF [Genotype: Ctrl, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/+, Itprka1091/+, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/Itprka1091]. Outer and inner dashed lines indicate borders of cell bodies and nuclei, respectively (Scale bar, 5 μm). (D) Quantification of Cyt/Nuc ratio of TBPH-Flag proteins in C4da neurons of Ctrl or Itprka1091/+ at 18 hr APF. **p=0.0054 by two-tailed t-test; error bars,± SEM; n = 9 for Ctrl, n = 8 for Itprka1091/+. (E) Subcellular localization of overexpressed TBPH-Flag proteins in C4da neurons of Ctrl or expressing SERCA RNAi (SERCA Ri) at 120 hr AEL [Genotype: Ctrl, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/+, SERCA Ri, UAS-SERCA RNAi/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/+]. Outer and inner dashed lines indicate borders of cell bodies and nuclei, respectively (Scale bar, 5 μm). (F) Quantification of Cyt/Nuc ratio of TBPH-Flag proteins in C4da neurons of Ctrl or expressing SERCA Ri at 120 hr AEL. ****p<1.0×10−4 by two-tailed t-test; error bars,± SEM; n = 6 for Ctrl, n = 13 for SERCA Ri. (G) Experimental scheme of optogenetics. The blue light (470 nm) was applied four times to the larvae at 5 days AEL to optogenetically stimulate C4da neurons expressing channelrhodopsin. (H) Subcellular localization of overexpressed TBPH-Flag proteins in C4da neurons of Ctrl (not illuminated) or illuminated larvae [Genotype: 20XUAS-Chr2.T159C-HA/+;UAS-ChR2.S/ppk1a-Gal4,UAS-TBPH-Flag-HA]. Outer and inner dashed lines indicate borders of cell bodies and nuclei, respectively (scale bar, 5 μm). (I) Quantification of Cyt/Nuc ratio of TBPH-Flag proteins in C4da neurons of Ctrl (not illuminated) or illuminated larvae. *p=0.0447 by two-tailed t-test; error bars, ± SEM; n = 12 neurons.

Given the relatively lower intracellular calcium level in larvae, we next increased the intracellular calcium level through a knockdown (SERCA Ri) of the Sarco/endoplasmic reticulum calcium ATPase (SERCA), a major calcium uptake pump in the ER. A higher GCaMP/tdTom mean intensity ratio confirmed the increased intracellular calcium level in the SERCA RNAi (Ri) larva (Figure 2—figure supplement 1E). In the SERCA Ri larvae, the majority of TBPH was translocated to the nucleus, resulting in a significantly (p<1.0 × 10−4) decreased Cyt/Nuc ratio (Figure 2E and F). We then increased the intracellular calcium level by overexpressing NachBac (NachBac O/E), a plasma membrane sodium channel, known to increase intracellular calcium level (Nitabach et al., 2006). Consistently, NachBac overexpression led to a similar decrease in Cyt/Nuc ratio of TBPH to that in the SERCA Ri larvae (Figure 2—figure supplement 1F and G).

Knockdown and overexpression experiments lead to chronic changes in calcium level, potentially activating compensatory mechanisms that may be responsible for the redistribution of TBPH. To reduce the possibility of activating compensatory mechanism from chronically increasing cytosolic calcium, we decided to increase intracellular calcium level in larval C4da neurons using an optogenetics technique. We first confirmed that upon optogenetic activation the larvae raised on food containing all trans-retinal (ATR) showed a mild increase (~20%) in intracellular calcium level in C4da neurons expressing channelrhodpsin (Figure 2—figure supplement 1H and I; Figure 2—video 1). This increase in calcium was sufficient to cause rolling response in larvae, a behavior previously shown to be elicited by increased intracellular calcium in C4da neurons (Figure 2—video 2; Hwang et al., 2007; Kaneko et al., 2017). Next, the larvae expressing channelrhodopsin and TBPH-Flag in C4da neurons were raised on food containing ATR. When the larvae reached the wandering third instar stage, they were put under the blue light (470 nm) for 30 min and then in the dark for 1 hr, and this light on/off cycle was repeated four times to a total of 120 min of light exposure. After the last off cycle of 1 hr, the larvae were dissected and immunostained for TBPH using anti-Flag antibody before imaging (Figure 2G). The Cyt/Nuc ratio of TBPH significantly (p<0.05) decreased compared to the controls that did not receive any blue light (Figure 2H and I). We also expressed RFP-tagged human TDP-43 in C4da neurons and applied the same optogenetics protocol (Figure 2G) before imaging them live. A similar decrease in Cyt/Nuc ratio was observed for the RFP-TDP-43 (Figure 2—figure supplement 1J and K) upon optogenetic stimulation. When we decreased the total amount of larval exposure to blue light to just 5 min, the Cyt/Nuc ratio of RFP-TDP-43 did not change at any of the time points (1, 30, 60, 90, and 120 min) imaged after the exposure (data not shown), suggesting that 5 min of increased cytosolic calcium is not enough to alter RFP-TDP-43 localization.

Next, we examined the subcellular localization of ALS-linked mutant TDP-43 G287S (Voigt et al., 2010) and tested whether developmental process or calcium can alter its localization. As expected, the localization of TDP-43 WT significantly changed from the cytoplasm in larvae to the nucleus in pupae (Figure 2—figure supplement 2A and B). The localization of TDP-43 G287S also shifted from the cytoplasm to the nucleus, albeit less so compared to TDP-43 WT. When we decreased cytosolic calcium via ryanodine receptor (RyR) knockdown in pupae, the Cyt/Nuc ratio of TDP-43 WT increased significantly. The localization of TDP-43 G287S also shifted back toward the cytoplasm, but the magnitude of the shift was again smaller than that of TDP-43 WT (Figure 2—figure supplement 2A and B). These data suggest that TDP-43 G287S is less sensitive than TDP-43 WT to the changes in development and cytosolic calcium in mediating NCT. Overall, altering cytosolic calcium in a variety of ways led to significant changes in the localization of TBPH/TDP-43, suggesting that calcium—and not other secondary causes arising from altering calcium-associated channels—regulates the nucleocytoplasmic localization of TBPH/TDP-43.

From these experiments, it is difficult to tell whether there is a decrease in nuclear export or an increase in nuclear import of TDP-43 when cytosolic calcium is increased. To test which is the case, we employed fluorescence recovery after photobleaching (FRAP) and optogenetic techniques to characterize the mobility of RFP-TDP-43 across the nuclear envelope upon stimulation (Figure 3A). First, we raised one group of larvae in food with ATR (ATR+) and another in food without ATR (ATR-). We then optogenetically stimulated third instar larvae from both groups for 30 min, increasing the intracellular calcium level only in those raised in ATR+. After incubation in the dark for 2 hr, we photobleached the nucleus of C4da neurons of larvae from both groups and examined the fluorescence recovery of RFP-TDP-43 (Figure 3B). C4da neurons in larvae that were raised in ATR+ food showed a significantly faster (t1/2: 24.9 s; tplateau: 146.3 s; slopemax: 0.01498) recovery of fluorescence in the nucleus compared to those raised in ATR- (t1/2: 46.7 s; tplateau: 200.9 s; slopemax: 0.00528) (Figure 3C and D). Taken together, these data suggest that cytosolic calcium facilitates nuclear import of TBPH in C4da neurons in larvae and pupae.

Optogenetic stimulation facilitates nuclear import of RFP-TDP-43 in C4da neurons.

(A) An experimental scheme of fluorescence recovery after photobleaching (FRAP) analysis of RFP-TDP-43 in the nucleus to assess its nuclear import after optogenetic stimulation. (B) Time-lapsed images of RFP-TDP-43 (pseudo-colored image) nuclear import dynamics in C4da neurons. Nuclear area is selected as region of interest (ROI) (scale bar, 5 μm). (C) FRAP analysis comparing recovery kinetics of RFP-TDP-43 signal in the nucleus of C4da neurons of larvae raised in food with no ATR (ATR -) or with ATR (ATR +) at 120 hr AEL [Genotype: 20XUAS-ChR2.T159C-HA/+;UAS-3xMyc-RFP-TDP-43/ppk1a-Gal4]. error bars,± SEM; n = 5 for ATR-, n = 7 for ATR+. (D) Analysis of FRAP data from C.

Calcium-dependent regulators and nuclear import components regulate nucleocytoplasmic translocation of TBPH/TDP-43

Next, we asked how cytosolic calcium mediates nuclear import of TBPH. TBPH itself has no calcium-binding motif, suggesting a possibility that calcium indirectly mediates its nucleocytoplasmic translocation through calcium-dependent regulators. To test this possibility, we performed an RNAi screen of 12 calcium-dependent regulators (Figure 4A) using pupal C4da neurons. Considering that TBPH is primarily localized to the nucleus in pupae, we searched for calcium-dependent regulators that could shift the TBPH localization toward the cytoplasm when their expression was reduced. Among the 12 regulators, knockdown of Calmodulin (Cam), Protein kinase C (Pkc53E), and Calpain-A (CalpA) considerably shifted the localization of TBPH toward the cytoplasm compared to the controls (Figure 4B), thereby significantly (p<0.05) increasing Cyt/Nuc ratios (Figure 4C).

Figure 4 with 2 supplements see all
Identification of calcium-dependent regulators associated with nucleocytoplasmic translocation of TBPH by a genetic screen.

(A) List of calcium-dependent regulators screened in this study. (B) Subcellular localization of overexpressed TBPH-Flag proteins co-overexpressed with denoted RNAi (Ri) transgenes in C4da neurons at 18 hr APF [Genotype: Ctrl, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/+, Cam Ri, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/UAS-Cam RNAi, CanA-14F Ri, UAS-CanA-14F RNAi/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/+, CanB Ri, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/UAS-CanB RNAi, CaMKI Ri, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/UAS-CaMKI RNAi/+, CaMKII Ri, UAS-CaMKII RNAi/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/+, Pka-C1 Ri, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/UAS-Pka-C1 RNAi, Pkc53E Ri, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/UAS-Pkc53E RNAi, CalpA Ri, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/UAS-CalpA RNAi, CalpB Ri, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/UAS-CalpB RNAi, NFAT Ri, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/UAS-NFAT RNAi, nej Ri, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/UAS-nej RNAi, CrebB Ri, UAS-CrebB RNAi/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/+]. Outer and inner dashed lines indicate borders of cell bodies and nuclei, respectively (scale bar, 5 μm). (C) Quantification of Cyt/Nuc ratio of TBPH-Flag proteins in C4da neurons expressing denoted transgenes described in B. ****p<1.0×10−4, **p=0.0053, *p=0.0276 by one-tailed t-test; error bars, ± SEM; n = 29 for Ctrl, n = 15 for Cam Ri, n = 3 for CanA-14F Ri, n = 10 for CanB Ri, n = 15 for CaMKI Ri, n = 9 for CaMKII Ri, n = 9 for Pka-C1 Ri, n = 7 for Pkc53E Ri, n = 17 for CalpA Ri, n = 5 for CalpB Ri, n = 4 for NFAT Ri, n = 9 for nej Ri, n = 13 for CrebB Ri.

The NLS of TBPH has been well-characterized (Winton et al., 2008) and we have shown above that upon optogenetic stimulation (Figure 2H and I), TBPH is actively transported into the nucleus. In contrast, the NES of TBPH is poorly understood, and the NES of TDP-43 was shown to be insufficient to export TDP-43 from the nucleus (Pinarbasi et al., 2018). Therefore, we performed an RNAi screen of 12 components involved in nuclear import (Figure 4—figure supplement 1A) using pupal C4da neurons. Among the 12 components, knockdown of Importin alpha 1 (Imp α1), Importin alpha 3 (Imp α3), Importin beta 1 (Imp β1), Importin 7 (Imp 7), and Transportin-Serine/Arginine rich (Tnpo-SR) considerably shifted the localization of TBPH toward the cytoplasm (Figure 4—figure supplement 1B) and significantly increased Cyt/Nuc ratios (Figure 4—figure supplement 1C). We then overexpressed Imp α3 and Imp β1 (knockdown of which resulted in the largest increase in Cyt/Nuc ratio) in larval C4da neurons and examined the changes in Cyt/Nuc ratio of TBPH. Consistent with the findings from knockdown experiments, overexpression of Imp α3 (Imp α3 O/E), Imp β1 (Imp β1 O/E), or Imp α3 and Imp β1 (Imp α3 O/E + Imp β1 O/E) shifted the localization of TBPH from the cytoplasm to the nucleus (Figure 4—figure supplement 2A and B). Taken together, these data suggest that calcium-dependent regulators and nuclear import components control nucleocytoplasmic translocation of TBPH.

Calpain-A controls the nucleocytoplasmic distribution of Importin α3

The above data suggest a possible regulatory relationship between calcium-dependent regulators and nuclear import components. To test this regulatory relationship, we chose two representative molecules, CalpA and Imp α3, from the selected calcium-dependent regulators and nuclear import components, respectively. According to the genetic screen, knockdown of Imp α3 (Figure 4—figure supplement 1C) and CalpA (Figure 4C) showed the largest and second largest effect on Cyt/Nuc ratio of TBPH, respectively. Although knockdown of Cam showed the largest effect on Cyt/Nuc ratio of TBPH (Figure 4C), we focused more on CalpA rather than Cam for further mechanistic study because co-overexpression of TBPH with Cam in C4da neurons induced lethality. We next generated transgenic fly lines co-overexpressing flag-tagged Imp α3 and myc-tagged CalpA in larval C4da neurons and examined the localization pattern of Imp α3. In control larvae, Imp α3 localized mainly in the cytoplasm (Figure 5—figure supplement 1A and B). Co-overexpression of CalpA, however, increased the amount of Imp α3 in the nucleus compared to the controls, and significantly (p<1.0 × 10−3) decreased the Cyt/Nuc ratio of Imp α3 (Figure 5—figure supplement 1A and B). In control pupae, Imp α3 is localized mainly in the nucleus. Knockdown of CalpA significantly shifted the localization of Imp α3 toward the cytoplasm compared to the controls, thereby increasing the Cyt/Nuc ratio of Imp α3 (Figure 5A and B). Knockdown of SERCA, which increases the amount of cytosolic calcium, also significantly (p<0.05) decreased Cyt/Nuc ratio of Imp α3 (Figure 5C and D), similar to CalpA co-overexpression. These data suggest that both cytosolic calcium and CalpA positively regulate nuclear localization of Imp α3.

Figure 5 with 1 supplement see all
Regulation of nucleocytoplasmic translocation of TBPH by the calcium-CalpA-Imp α3 pathway.

(A) Subcellular localization of overexpressed Flag-Imp α3 proteins in C4da neurons of Ctrl (at 120 hr AEL and 18 hr APF) or with CalpA knockdown (CalpA Ri) at 18 hr APF [Genotype: Ctrl, UAS-2xFlag-Imp α3/+;ppk1a-Gal4/+, CalpA Ri, UAS-2xFlag-Imp α3;ppk1a-Gal4/UAS-CalpA RNAi]. Outer and inner dashed lines indicate borders of cell bodies and nuclei, respectively (scale bar, 5 μm). (B) Quantification of Cyt/Nuc ratio of Flag-Imp α3 proteins in C4da neurons of Ctrl (at 120 hr AEL and 18 hr APF) or with CalpA knockdown (CalpA Ri) at 18 hr APF. ***p=0.0005, **p=0.0031 by two-tailed t-test; error bars, ± SEM; n = 6 for Ctrl of 120 hr AEL, n = 9 for Ctrl and CalpA Ri of 18 hr APF. (C) Subcellular localization of overexpressed Flag-Imp α3 proteins in C4da neurons of Ctrl or expressing SERCA Ri or both SERCA Ri and CalpA Ri at 120 hr AEL [Genotype: Ctrl, UAS-2xFlag-Imp α3/+;ppk1a-Gal4/+, SERCA Ri, UAS-2xFlag-Imp α3/UAS-SERCA RNAi;ppk1a-Gal4/+, SERCA Ri + CalpA Ri, UAS-2xFlag-Imp α3/UAS-SERCA RNAi;ppk1a-Gal4/UAS-CalpA RNAi]. Outer and inner dashed lines indicate borders of cell bodies and nuclei, respectively (scale bar, 5 μm). (D) Quantification of Cyt/Nuc ratio of Flag-Imp α3 proteins in C4da neurons of Ctrl or expressing SERCA Ri or both SERCA Ri and CalpA Ri at 120 hr AEL. **p=0.0024, *p=0.0219 by two-tailed t-test; error bars, ± SEM; n = 19 for Ctrl, n = 11 for SERCA Ri, n = 15 for SERCA Ri + CalpA Ri. (E) Subcellular localization of overexpressed TBPH-Flag proteins in C4da neurons of Ctrl or expressing SERCA Ri or both SERCA Ri and Imp α3 Ri at 120 hr AEL [Genotype: Ctrl, +/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/+, SERCA Ri, UAS-SERCA RNAi/+;ppk1a-Gal4,UAS-TBPH-Flag-HA/+, SERCA Ri + Imp α3 Ri, UAS-SERCA RNAi/UAS-Imp α3 RNAi;ppk1a-Gal4,UAS-TBPH-Flag-HA/+]. Outer and inner dashed lines indicate borders of cell bodies and nuclei, respectively (scale bar, 5 μm). (F) Quantification of Cyt/Nuc ratio of TBPH-Flag proteins in C4da neurons of Ctrl or expressing SERCA Ri or both SERCA Ri and Imp α3 Ri at 120 hr AEL. ****p<1.0×10−4 by two-tailed t-test; error bars, ± SEM; n = 12 for Ctrl, n = 8 for SERCA Ri, n = 6 for SERCA Ri + Imp α3 Ri. (G) A schematic model for the regulatory mechanism of nucleocytoplasmic TBPH involving the cytosolic calcium-CalpA-Imp α3 pathway. Arrows indicate experimentally validated functional links, and dashed lines indicate possible alternative paths in addition to the validated cytosolic calcium-CalpA-Imp α3 pathway.

We next questioned whether cytosolic calcium induces nuclear localization of Imp α3 via CalpA. To answer this question, we examined the nucleocytoplasmic localization of Imp α3 in larval C4da neurons co-overexpressing SERCA Ri and CalpA Ri (SERCA Ri + CalpA Ri). In these C4da neurons, Imp α3 was predominantly localized in the cytoplasm, implying that the effect of SERCA knockdown was abolished by the CalpA knockdown (Figure 5C and D). We showed above that TBPH was predominantly localized to the nucleus in larval C4da neurons overexpressing SERCA Ri. However, co-overexpression of SERCA Ri and Imp α3 Ri (SERCA Ri + Imp α3 Ri) reversed the TBPH localization from the nucleus to the cytoplasm (Figure 5E and F). These data collectively suggest that cytosolic calcium controls Imp α3-mediated nuclear localization of TBPH via CalpA (Figure 5G).

An untimely nuclear mis-localization of TDP-43 in larval C4da neurons is associated with dysregulation of dendrite arborization

We have shown above that changes in the cytosolic calcium level can markedly shift the localization of TBPH from the cytoplasm to the nucleus and vice versa. This suggests a possibility that upon specific cellular demands for its location-specific functions, TBPH localization might be dynamically changed. Moreover, in cells with lower cytosolic calcium level, such as in larval C4da neurons, cellular demands for nuclear function of TBPH may be minimal. If this is true, inducing nuclear localization of TBPH or TDP-43 in larval C4da neurons may lead to an untimely function and thus an undesirable outcome. To test this, we expressed in larval C4da neurons TDP-43 (TDP-43 WT O/E) or TDP-43 with mutations to NLS (TDP-43-ΔNLS O/E) and examined neuronal morphology as a readout for cell biological consequence of nuclear TDP-43 localization (Figure 6A). Previous studies showed that the expression of TDP-43 can alter dendrite morphology (Lu et al., 2009; Schwenk et al., 2016; Herzog et al., 2017; Herzog et al., 2020), but the extent to which its nuclear function is involved remains less known. Interestingly, we found that C4da neurons expressing TDP-43 showed more aberrant dendrite arborization pattern compared to those expressing TDP-43-ΔNLS (Figure 6A). Although TDP-43-ΔNLS has been shown to be more toxic in some model systems such as rat cortical neurons (Barmada et al., 2010), a study using the same constructs as we did reported stronger toxicity induced by wild-type form of TDP-43 than by TDP-43-ΔNLS in certain types of cells (Miguel et al., 2011). Further analysis showed that C4da neurons expressing TDP-43 exhibited significantly shorter total dendritic length (Figure 6B) and fewer number of dendritic branch points compared to those expressing TDP-43-ΔNLS (Figure 6C). Also, sholl analysis indicated that the complexity of dendritic arbor in C4da neurons expressing TDP-43 was significantly reduced compared to those expressing TDP-43-ΔNLS and controls (Figure 6D). Consistently, manipulating cytosolic calcium to alter the localization of overexpressed TBPH also led to similar dendritic phenotypes. SERCA knockdown, which promotes nuclear translocation of overexpressed TBPH, decreased the total dendritic length (Figure 6E and F) and the number of dendritic branch points (Figure 6E and G) in larval C4da neurons. Itpr knockdown (Figure 6E and G) or mutants (Figure 6—figure supplement 1A–1C), which inhibit nuclear translocation of overexpressed TBPH, increased the total dendritic length and the number of dendritic branch points. Moreover, overexpression and knockdown of Imp α3 significantly decreased and increased, respectively, the total dendritic lengths (Figure 6—figure supplement 1D and E) and the number of dendritic branch points (Figure 6—figure supplement 1D and F) of C4da neurons overexpressing TBPH. Furthermore, Imp α3 Ri significantly increased the dendritic complexity of TBPH O/E, whereas Imp α3 O/E decreased the complexity (Figure 6—figure supplement 1G). These data indicate that increasing the dosage of nuclear—but not cytoplasmic—TBPH is highly toxic in larval C4da neurons.

Figure 6 with 3 supplements see all
Significant alteration in the dendrite arborization of larval C4da neurons resulted from an untimely nuclear mis-localization of TBPH/TDP-43.

(A) Skeletonized dendrite images of C4da neurons of larvae with denoted genotypes [Genotype: Ctrl, +/+;ppk1a-Gal4,UAS-CD4-tdGFP/+, TDP-43 WT O/E, UAS-TDP-43/+;ppk1a-Gal4, UAS-CD4-tdGFP/+, TDP-43-ΔNLS O/E, UAS-TDP-43-ΔNLS/+;ppk1a-Gal4, UAS-CD4-tdGFP/+]. Magnified images are presented at the bottom (Red scale bar, 100 μm; Blue scale bar, 50 μm). (B) Quantification of total dendritic length in neurons expressing the denoted transgenes. ****p<1.0×10−4 by two-tailed t-test; error bars, ± SEM; n = 8 for Ctrl, n = 20 for TDP-43 WT O/E, n = 12 for TDP-43-ΔNLS O/E. (C) Quantification of the number of dendritic branch points in neurons expressing the denoted transgenes. ****p<1.0×10−4 by two-tailed t-test; error bars, ± SEM; n = 8 for Ctrl, n = 20 for TDP-43 WT O/E, n = 12 for TDP-43-ΔNLS O/E. (D) Sholl analysis of neurons expressing the denoted transgenes. (E) Skeletonized dendrite images of C4da neurons of larvae with denoted genotypes [Genotype: TBPH O/E, UAS-TBPH/+;ppk1a-Gal4,UAS-CD4-tdGFP/+, TBPH O/E + SERCA Ri, UAS-TBPH/UAS-SERCA RNAi;ppk1a-Gal4,UAS-CD4-tdGFP/+, TBPH O/E + Itpr Ri, UAS-TBPH/UAS-Itpr RNAi;ppk1a-Gal4,UAS-CD4-tdGFP/+]. Magnified images are presented at the right side (Red scale bar, 40 μm; Blue scale bar, 20 μm). (F) and (G) Quantifications of total dendritic length (F) and number of dendritic branch points (G) in neurons expressing the denoted transgenes. ****p<1.0×10−4, **p=0.0045, n.s., not significant, p=0.0655 by two-tailed t-test; error bars, ± SEM; n = 13 for TBPH O/E, n = 11 for TBPH O/E + SERCA Ri, n = 9 for TBPH O/E + Itpr Ri.

To examine through which molecular complex nuclear TBPH induces aberrant dendrite arborization phenotype, we screened for splicing factors (Figure 6—figure supplement 2A) whose knockdown mitigated nuclear TBPH-mediated dendrite phenotype. We identified through the screen Hrb27C (Figure 6—figure supplement 2B–2E), the human homolog for which is DAZAP1 (Matunis et al., 1992). Taken together, these results support the notion that expression of TBPH/TDP-43 in a location different from its original cell-type-specific location is deleterious, whether it is a mis-localization from the nucleus to the cytoplasm as observed in Drosophila retina (Figure 6—figure supplement 3A–3C) or from the cytoplasm to the nucleus as in C4da neurons.

Increased cytosolic calcium restores defects in TBPH localization and larval locomotion in C9orf72 ALS models

We showed above that altering the localization of TBPH can lead to an untimely functional output, leading to undesirable outcomes. In contrast to Drosophila larval C4da neurons, motor neurons in Drosophila larvae present predominantly nuclear TBPH. In motor neurons of ALS patients and model systems, depletion of TDP-43 in the nucleus (loss of function) and accumulation of TDP-43 in the cytoplasm (gain of toxicity)—both of which increase the Cyt/Nuc ratio of TDP-43—are crucial pathological features (Neumann et al., 2006; Hergesheimer et al., 2019). It has been reported that the increased Cyt/Nuc ratio of TDP-43 is observed in ~97% of ALS patients (Ling et al., 2013) and in ALS animal models (Wils et al., 2010; Li et al., 2010). These observations combined with our current data suggest a hypothesis that increasing cytosolic calcium may restore the dysregulated Cyt/Nuc ratio of TDP-43 in ALS. To test this hypothesis, we employed ALS fly models with motor neurons overexpressing arginine-rich dipeptide repeat proteins (DPRs: PR100 and GR100) derived from the GGGGCC repeat expansion in C9orf72, the most commonly mutated gene in ALS (DeJesus-Hernandez et al., 2011; Renton et al., 2011). We first confirmed that the Cyt/Nuc ratio of TBPH was increased in the PR100- and GR100-expressing larval motor neurons (Figure 7A left panels and 7B), compared to in the control (Ctrl), consistent with previous observation in adult fly brains (Solomon et al., 2018). We then increased the amount of cytosolic calcium in motor neurons of these ALS fly models by co-overexpressing SERCA Ri with PR100 or GR100. Increased cytosolic calcium restored the Cyt/Nuc ratio of TBPH significantly (p<0.05) in the PR100- and GR100-expressing larval motor neurons (Figure 7A right panels and 7B).

Figure 7 with 4 supplements see all
Restoration of aberrant TBPH localization and defective larval locomotion in C9orf72 ALS models by increased cytosolic calcium.

(A) Subcellular localization of endogenous TBPH proteins in larval motor neurons of w1118 or overexpressing PR100 or GR100, accompanied by concomitant expression of 40DUAS control vector (Ctrl) or SERCA Ri (SERCA Ri) at 120 hr AEL [Genotype: w1118 in Ctrl, 40DUAS/+;D42-Gal4,UAS-mCD8-RFP/+, PR100 O/E in Ctrl, 40DUAS/UAS-poly-PR.PO-100;D42-Gal4,UAS-mCD8-RFP/+, GR100 O/E in Ctrl, 40DUAS/UAS-poly-GR.PO-100;D42-Gal4,UAS-mCD8-RFP/+, w1118 in SERCA Ri, UAS-SERCA RNAi/+;D42-Gal4,UAS-mCD8-RFP/+, PR100 O/E in SERCA Ri, UAS-SERCA RNAi/UAS-poly-PR.PO-100;D42-Gal4,UAS-mCD8-RFP/+, GR100 O/E in SERCA Ri, UAS-SERCA RNAi/UAS-poly-GR.PO-100;D42-Gal4,UAS-mCD8-RFP/+]. Merged immunohistochemical images of endogenous TBPH proteins (green), plasma membranes (red), and DAPI (blue) are presented on the left side. Four neurons from the A3-A5 region of the VNC are selected as representative images (marked by yellow squares) and their enlarged images are shown on the right. Outer and inner dashed lines indicate borders of cell bodies and nuclei, respectively (yellow scale bar, 5 μm). (B) Quantification of Cyt/Nuc ratio of endogenous TBPH proteins in larval motor neurons expressing denoted transgenes described in A. N.S., not significant, p>0.05, ****p<1.0×10−4, *p<0.05 by two-tailed t-test; error bars, ± SEM; n = 30 for w1118 in Ctrl, n = 20 for PR100 O/E in Ctrl, n = 30 for GR100 O/E in Ctrl; n = 20 for w1118 in SERCA Ri, n = 20 for PR100 O/E in SERCA Ri, n = 30 for GR100 O/E in SERCA Ri. (C) Heat maps showing residence probability during traveling of larvae [Genotype: w1118 in Ctrl, 40DUAS/+;D42-Gal4,UAS-mCD8-RFP/+, w1118 in SERCA Ri, UAS-SERCA RNAi/+;D42-Gal4,UAS-mCD8-RFP/+, GR100 O/E in Ctrl, 40DUAS/UAS-poly-GR.PO-100;D42-Gal4,UAS-mCD8-RFP/+, GR100 O/E in SERCA Ri, UAS-SERCA RNAi/UAS-poly-GR.PO-100;D42-Gal4,UAS-mCD8-RFP/+] monitored in the 90 mm Petri dish until the larvae reached the edge of Petri dish or for up to 60 s. (D) Quantification of total distances traveled during 10 s for larvae expressing denoted genotypes in motor neurons described in C. n.s., not significant, p>0.05, **p=0.0048 by two-tailed t-test; error bars, ± SEM; n = 23 for w1118 in Ctrl, n = 28 for GR100 O/E in Ctrl; n = 28 for w1118 in SERCA Ri, n = 23 for GR100 O/E in SERCA Ri.

Movement defects are one of the main pathological features in ALS. Thus, we next examined whether increasing cytosolic calcium can rescue larval locomotion defects derived from overexpression of GR100 in motor neurons of the ALS fly model. We placed a larva in the center of the Petri dish containing 3% agar and then measured the total distance it travelled in 10 s. This experiment was carried out for w1118 larvae overexpressing control vector (Ctrl), SERCA Ri, GR100 and control vector (GR100 O/E + Ctrl), and GR100 and SERCA Ri (GR100 O/E + SERCA Ri) (Figure 7C). After repeating the experiments using more than 23 different larvae for each genotype, we found that larvae overexpressing SERCA Ri showed no significant change in the distance travelled compared to the controls, whereas those overexpressing GR100 showed a significant (p<0.05) decrease compared to the controls. The larvae co-overexpressing GR100 and SERCA Ri travelled a longer distance than those expressing only GR100 (Figure 7D), indicating mitigation of larval locomotion defect. Taken together, these data suggest that increasing cytosolic calcium can restore defects in TBPH localization and larval locomotion, at least in C9orf72 ALS models.

Discussion

In this study, we demonstrate a role of the calcium-CalpA-Imp α3 pathway in regulation of cytoplasmic accumulation of TDP-43. The involvement of this pathway further extends the previously proposed feedback cycle model (Solomon et al., 2018). In the previous model, amounts of cytoplasmic TDP-43 are increased through NCT defects caused by cytoplasmic aggregation of TDP-43, and increased levels of TDP-43 in the cytoplasm further accelerate TDP-43 aggregation. Our results provide an additional pathway that can increase the amounts of cytoplasmic TDP-43. How the calcium-CalpA-Imp α3 pathway interacts with the events in the feedback cycle model during progression of ALS is not certain. Interestingly, although modulation of cytosolic calcium levels led to reversible translocation of TDP-43 between the cytoplasm and the nucleus, TDP-43 aggregates were not observed in our study. Given this observation, the calcium-CalpA-Imp α3 pathway is likely to precede the sequestration of Importins by cytoplasmic TDP-43 aggregates and the subsequent NCT defects in the feedback cycle model. Therefore, our results provide an early regulatory mode to be therapeutically targeted for prevention of cytoplasmic accumulation of TDP-43 in ALS (Figure 7—figure supplement 1). In addition, we showed calcium-dependent dynamic changes of TDP-43 localization in neurons in response to the changes in cellular context during development. Together with a recent study showing shift in TDP-43 localization from nucleus to cytoplasm in skeletal muscle cells during regeneration (Vogler et al., 2018), our results suggest that translocation of TDP-43 is not necessarily pathological. This conclusion is supported by a recent study in which nuclear depletion and cytoplasmic accumulation of TDP-43 were observed in a subpopulation of neurons from various areas of healthy mouse brain (Termsarasab et al., 2020). These findings raise a new possibility that dynamic control of TDP-43 translocation can contribute to cytoplasmic accumulation of TDP-43 in ALS (Figure 7—figure supplement 2).

Among the candidate molecules selected from the genetic screen (Figure 4 and Figure 4—figure supplement 1), we focused on CalpA and Imp α3 during the search of the mechanism. However, in addition to CalpA and Imp α3, the candidate molecules also included two other calcium-dependent regulator candidates (Cam and Pkc53E) and four other nuclear import components (Imp α1, Imp β1, Imp 7, and Tnpo-SR). Cam acts as a nuclear transporter of sex-determining region Y (SRY), independent of Importin (Kaur et al., 2010). However, Cam was excluded from the following experiments because of no Cam-binding site in TBPH, as well as the lethality induced by its overexpression. In contrast, Pkc53E regulates nucleocytoplasmic localization of diacylglycerol kinase ζ (Topham et al., 1998) and ribosomal protein S6 kinase (S6K) by inhibiting functions of their NLSs via phosphorylation (Valovka et al., 2003). Pkc53E showed a comparable effect to CalpA on the localization of TBPH (Figure 4C). These data suggest the existence of an additional, Pkc53E-dependent pathway to regulate TBPH localization. Imp αs are known to form heterodimers with Imp βs (Moroianu et al., 1995, Jäkel et al., 1999) , suggesting that Imp α3 and Imp β1 may form a heterodimer to participate in our pathway. Indeed, disrupting this pathway via reducing CalpA level appears to interfere with nuclear translocation of another NLS-bearing protein, polyQ (MJDtr-78Q; Figure 7—figure supplement 3A), which is known to be transported via Imp α3 (Sowa et al., 2018). Notably, a reduction in CalpA mitigated polyQ-induced retinal degeneration (Figure 7—figure supplement 3B). These data suggest that calcium-mediated CalpA activity may affect nuclear localization of a broad range of proteins via Imp α3.

Calpains have been associated with neurotoxicity in a number of diseases including ALS (Vosler et al., 2008). There are 15 genes encoding calpains in mammals (Evans and Turner, 2007), among which Calpain-1 and −2 are most studied. In Neuro2a cells and in motor cortex of patients with frontotemporal lobar degeneration with clinical features of motor neuron disease (FTLD-MND), Yamashita et al., 2012 showed that Calpain-1 and −2 are responsible for the calcium-mediated cleavage of TDP-43, leading to its toxic accumulation in the cytoplasm. Calpain-mediated cleavage of TDP-43 into CTF-25 and CTF-35 during traumatic brain injury in mice has also been reported (Yang et al., 2014). In Drosophila, CalpA is most similar to Calpain-9 (Thurmond et al., 2019). Therefore, some of the functions of Calpain-1 and −2, such as cleavage of TDP-43, may not be conserved in CalpA. To test whether CalpA used in this study can also cleave TBPH, we overexpressed CalpA in fly heads and measured the amount and size of TBPH via western blot and compared them to the control. We found that CalpA overexpression led to no apparent pattern of TBPH cleavage on the blot (Figure 7—figure supplement 4A and B), although unexpectedly, it led to an increase in the amount of TBPH. Instead, we showed that CalpA is necessary for nuclear import of TBPH (Figure 4B and C) through a yet undefined mechanism. These data suggest that CalpA, unlike Calpain-1 and −2, does not cleave TBPH and instead may be protective against TBPH-mediated toxicity.

Knockdown of CalpA blocked nuclear translocation of Imp α3 in pupal C4da neurons (Figure 5A and B), suggesting that CalpA functions as an upstream regulator of Imp α3. A specific mechanism by which CalpA regulates TBPH translocation through Imp α3 remains to be shown. Calpain, a human orthologue of CalpA, is a protease with a broad spectrum of substrates (DuVerle et al., 2011). However, Importin α3, a human orthologue of Imp α3, has not been reported as a substrate of Calpain, nor predicted using the Calpain cleavage detector (CCD) software (Liu et al., 2011). These data suggest the possibility that CalpA regulates nuclear translocation of Imp α3 indirectly via its another target protein associated with nuclear import or export of Imp α3. Further functional study is needed to test the validity of this hypothesis.

Based on our data, Imp α3/β1 complex is the major transport regulator for nuclear import of TBPH (Figure 4—figure supplement 2A and B). Interestingly, knockdown of Imp α1, Tnpo-SR, and Imp seven also led to a significant shift in TBPH localization from the nucleus to the cytoplasm in pupae. TDP-43 has been shown to interact with both KPNA4 and KPNA6, the orthologs for which are Imp α3 and Imp α1, respectively (Nishimura et al., 2010). Interestingly, ectopic expression of Imp α1 in Drosophila eyes rescued glassy-eye phenotype of Imp α3 mutant (Mason et al., 2003), suggesting that Imp α1 and Imp α3 have somewhat redundant functions. Thus, it is not surprising that knockdown of Imp α1 also disrupted nuclear transport of TBPH. Whether Imp α1 also receives regulation from CalpA remains to be shown. As for Imp7 and Tnpo-SR, they both function at the upstream of mRNA splicing. Imp7 binds directly to small nuclear ribonucleoproteins (snRNPs), which are indispensable constituents of a spliceosome, and localizes them into Cajal bodies (Natalizio and Matera, 2013). Now, spliceosome assembly is also mediated by serine/arginine-rich splicing factor 1 (SRSF1) (Cho et al., 2011), which is transported into the nucleus by Tnpo-SR (Allemand et al., 2002). Notably, 517 and 333 SRSF1-regulated alternative splicing events were identified in 3D MCF-10A acini and HeLa cells, respectively (Anczuków et al., 2015). We surmise that knockdown of Imp7 and Tnpo-SR may cause widespread changes in alternative splicing, the result of which may impede TBPH import into the nucleus.

We reported in this study that TBPH localization shifts from the cytoplasm (at larval period) to the nucleus (at pupal period), but for what reason TBPH translocates into the nucleus during the pupal stage remains unknown. Interestingly, a previous study (Vanden Broeck et al., 2013) showed that loss of function of TBPH leads to increased Map205 expression, resulting in cytoplasmic mis-localization of ecdysone receptor-A (EcR-A), an isoform of EcR expressed predominantly during the late stages of pupa. These results raise a possibility that in C4da neurons, TBPH translocates into the nucleus during pupal stage to regulate the expression of Map205 and thus the nuclear localization of EcR-A, an important step for proper metamorphosis. Of note, several previous studies showed that the loss of liver X receptor β (LXRβ), a mammalian ortholog of EcR, results in motor neuron degeneration (Andersson et al., 2005; Bigini et al., 2010) and that LXRβ physically interacts with TDP-43 (Vanden Broeck et al., 2013). Another previous study showed that LXRβ links β-sitosterol to ALS-parkinsonism dementia complex (Kim et al., 2008). Furthermore, single-nucleotide polymorphisms (SNPs) for LXRβ were recently identified to be associated with the age of onset in ALS patients (Mouzat et al., 2018). These studies strongly suggest that disrupted LXRβ (EcR) signaling pathway may be associated with motor neuron diseases such as ALS. Taken together, it seems possible that neurons dynamically control the nucleocytoplasmic translocation of TDP-43 upon specific cellular demands such as regulation of LXRβ signaling associated with ALS pathogenesis.

Previous studies reported that increased calcium was observed in motor neurons of ALS mouse models (von Lewinski and Keller, 2005). Together with the fact that excessive intracellular calcium over the manageable capacity is able to trigger cell death, these observations support the idea that decreasing calcium can be an effective strategy to treat ALS. Consistent with this idea, riluzole, the FDA-approved medication for ALS, appears to delay the disease progression for 3 months by inhibiting calcium-mediated excitotoxicity. However, in a recent post-hoc study, the beneficial effect of riluzole was shown to be evident at late stage of ALS (stage 4), but not at earlier stages (stages 2 and 3) (Fang et al., 2018). Consistent with this post-hoc study, a previous study suggested that early intrinsic hyperexcitability may not contribute to motor neuron degeneration in ALS (Leroy et al., 2014). Moreover, a potentially protective function of calcium in motor neurons of ALS models at their early developmental stages has been reported (Saxena et al., 2013; Armstrong and Drapeau, 2013). Taken together, these findings suggest a possibility that intracellular calcium may have a concentration-dependent shift in its net effect on ALS pathogenesis from being protective to pathogenic as disease progresses. Our finding of the calcium-CalpA-Imp α3 pathway may provide a mechanistic insight to understand the role of calcium in ALS pathogenesis.

Materials and methods

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Genetic reagent (D. melanogaster)w1118Bloomington Drosophila Stock Center (BDSC)RRID:BDSC_5905
Genetic reagent (D. melanogaster)D42-Gal4BDSCRRID:BDSC_8816
Genetic reagent (D. melanogaster)TH-Gal4BDSCRRID:BDSC_8848
Genetic reagent (D. melanogaster)repo-Gal4BDSCRRID:BDSC_7415
Genetic reagent (D. melanogaster)UAS-mCD8-RFPBDSCRRID:BDSC_27399
Genetic reagent (D. melanogaster)UAS-CD4-tdTomBDSCRRID:BDSC_35841
Genetic reagent (D. melanogaster)Itprka1091/+BDSCRRID:BDSC_30739
Genetic reagent (D. melanogaster)Itprsv35/+BDSCRRID:BDSC_30740
Genetic reagent (D. melanogaster)20XUAS-ChR2.T159C-HABDSCRRID:BDSC_52258
Genetic reagent (D. melanogaster)UAS-Chr2.sBDSCRRID:BDSC_9681
Genetic reagent (D. melanogaster)RyR16/+BDSCRRID:BDSC_6812
Genetic reagent (D. melanogaster)UAS-NachBacBDSCRRID:BDSC_9467
Genetic reagent (D. melanogaster)UAS-R-GECO1-IR1,UAS-R-GECO1.L-IR2BDSCRRID:BDSC_52222
Genetic reagent (D. melanogaster)UAS-Cam RNAiBDSCRRID:BDSC_34609
Genetic reagent (D. melanogaster)UAS-CanA-14F RNAiBDSCRRID:BDSC_58249
Genetic reagent (D. melanogaster)UAS-CanB RNAiBDSCRRID:BDSC_27307
Genetic reagent (D. melanogaster)UAS-CaMKI RNAiBDSCRRID:BDSC_35362
Genetic reagent (D. melanogaster)UAS-Pka-C1 RNAiBDSCRRID:BDSC_31599
Genetic reagent (D. melanogaster)UAS-Pkc53E RNAiBDSCRRID:BDSC_55864
Genetic reagent (D. melanogaster)UAS-CalpA RNAiBDSCRRID:BDSC_29455
Genetic reagent (D. melanogaster)UAS-CalpB RNAiBDSCRRID:BDSC_25963
Genetic reagent (D. melanogaster)UAS-NFAT RNAiBDSCRRID:BDSC_51422
Genetic reagent (D. melanogaster)UAS-nej RNAiBDSCRRID:BDSC_37489
Genetic reagent (D. melanogaster)UAS-CrebA RNAiBDSCRRID:BDSC_27648
Genetic reagent (D. melanogaster)UAS-CrebB RNAiBDSCRRID:BDSC_63681
Genetic reagent (D. melanogaster)UAS-Imp α1 RNAiBDSCRRID:BDSC_27523
Genetic reagent (D. melanogaster)UAS-Imp α2 RNAiBDSCRRID:BDSC_27692
Genetic reagent (D. melanogaster)UAS-Imp α3 RNAiBDSCRRID:BDSC_27535
Genetic reagent (D. melanogaster)UAS-Imp β1 RNAiBDSCRRID:BDSC_31242
Genetic reagent (D. melanogaster)UAS-Imp 7 RNAiBDSCRRID:BDSC_33626
Genetic reagent (D. melanogaster)UAS-Imp β11 RNAiBDSCRRID:BDSC_55142
Genetic reagent (D. melanogaster)UAS-Tnpo RNAiBDSCRRID:BDSC_50732
Genetic reagent (D. melanogaster)UAS-Tnpo-SR RNAiBDSCRRID:BDSC_56974
Genetic reagent (D. melanogaster)UAS-Ran RNAiBDSCRRID:BDSC_42482
Genetic reagent (D. melanogaster)UAS-Ntf-2 RNAiBDSCRRID:BDSC_28633
Genetic reagent (D. melanogaster)UAS-LuciferaseBDSCRRID:BDSC_35788
Genetic reagent (D. melanogaster)UAS-Hrb87F RNAiBDSCRRID:BDSC_52937
Genetic reagent (D. melanogaster)UAS-HNPNPC RNAiBDSCRRID:BDSC_42506
Genetic reagent (D. melanogaster)UAS-glo RNAiBDSCRRID:BDSC_33668
Genetic reagent (D. melanogaster)UAS-Syp RNAiBDSCRRID:BDSC_56972
Genetic reagent (D. melanogaster)UAS-poly-PR.PO-100BDSCRRID:BDSC_58698
Genetic reagent (D. melanogaster)UAS-poly-GR.PO-100BDSCRRID:BDSC_58696
Genetic reagent (D. melanogaster)Gmr-Gal4BDSCRRID:BDSC_1104
Genetic reagent (D. melanogaster)UAS-MJD-tr78QBDSCRRID:BDSC_8150
Genetic reagent (D. melanogaster)Df(2R)BSC26BDSCRRID:BDSC_6866
Genetic reagent (D. melanogaster)UAS-SERCA RNAiVienna Drosophila Resource Center (VDRC)VDRC: 107446; RRID:FlyBase_FBst0479267
Genetic reagent (D. melanogaster)UAS-Itpr RNAiVDRCVDRC: 106982; RRID:FlyBase_FBst0478805
Genetic reagent (D. melanogaster)UAS-RyR RNAiVDRCVDRC: 109631; RRID:FlyBase_FBst0481295
Genetic reagent (D. melanogaster)UAS-CaMKII RNAiVDRCVDRC: 100265; RRID:FlyBase_FBst0472139
Genetic reagent (D. melanogaster)UAS-Imp α3 RNAiVDRCVDRC: 106249; RRID:FlyBase_FBst0478074
Genetic reagent (D. melanogaster)UAS-RanGAP RNAiVDRCVDRC: 108264; RRID:FlyBase_FBst0480076
Genetic reagent (D. melanogaster)UAS-Rcc1 RNAiVDRCVDRC: 110321; RRID:FlyBase_FBst0481896
Genetic reagent (D. melanogaster)UAS-Hrb98DE RNAiVDRCVDRC: 29524; RRID:FlyBase_FBst0458009
Genetic reagent (D. melanogaster)UAS-Hrb27C RNAiVDRCVDRC: 101555; RRID:FlyBase_FBst0473428
Genetic reagent (D. melanogaster)UAS-HNRNPU1 RNAiVDRCVDRC:106984; RRID:FlyBase_FBst0478807
Genetic reagent (D. melanogaster)UAS-Sm RNAiVDRCVDRC:108351; RRID:FlyBase_FBst0480162
Genetic reagent (D. melanogaster)UAS-CalpA RNAiVDRCVDRC:101294; RRID:FlyBase_FBst0473167
Genetic reagent (D. melanogaster)40DUASVDRCVDRC ID: 60101
Genetic reagent (D. melanogaster)UAS-TBPH-Flag-HABangalore Fly Resource CenterDrosophila
Protein interaction
Map (DPiM)
Genetic reagent (D. melanogaster)ppk1a-Gal4Han et al., 2011; Yuh Nung Jan (University of California, San Francisco (UCSF))
Genetic reagent (D. melanogaster)UAS-tdTomato P2A GCaMP5G, attp1Daniels et al., 2014; Barry Ganetzky (University of Wisconsin-Madison)
Genetic reagent (D. melanogaster)UAS-3xMyc-RFP-TDP-43Wang et al., 2011; Brian D. McCabe, (Swiss Federal Institute of Technology (EPFL))
Genetic reagent (D. melanogaster)UAS-TBPHWang et al., 2011; Brian D. McCabe, (Swiss Federal Institute of Technology (EPFL))
Genetic reagent (D. melanogaster)UAS-TDP-43 WTVoigt et al., 2010; Aaron Voigt (University Hospital, RWTH Aachen University)
Genetic reagent (D. melanogaster)UAS-TDP-43 G287SVoigt et al., 2010; Aaron Voigt (University Hospital, RWTH Aachen University)
Genetic reagent (D. melanogaster)UAS-Flag-TDP-43Miguel et al., 2011; Magalie Lecourtois (University of Rouen)
Genetic reagent (D. melanogaster)UAS-Flag-TDP-43-ΔNLSMiguel et al., 2011; Magalie Lecourtois (University of Rouen)
Genetic reagent (D. melanogaster)UAS-2xFlag-Imp α3 (vk00002)This paperSB Lab (DGIST)
Genetic reagent (D. melanogaster)UAS-V5-Imp β1 (vk00002)This paperSB Lab (DGIST)
Genetic reagent (D. melanogaster)UAS-CalpA-2xMyc (vk00002)This paperSB Lab (DGIST)
Genetic reagent (D. melanogaster)UAS-emptyPark et al., 2020SB Lab (DGIST)
AntibodyMouse monoclonal anti-Flag (DYKDDDDK)WakoCat#: 012–22384; RRID:AB_10659717IHC (1:400)
AntibodyRat monoclonal anti-HARocheCat#: 11867423001; RRID:AB_390918IHC (1:200)
AntibodyRabbit anti-TBPHLTK BioLaboratories, Taiwan;
(Lin et al., 2011); C.-K. James Shen (Taipei Medical University)
IHC (1:100)
AntibodyRabbit polyclonal anti-TDP-43ProteintechCat#: 10782–2-AP, RRID:AB_615042IHC (1:400)
AntibodyGoat polyclonal anti-mouse Alexa Fluor 647InvitrogenCat#: A21236; RRID:AB_2535805IHC (1:400)
AntibodyGoat polyclonal anti-rat Alexa Fluor 647Jackson Immunoresearch LaboratoriesCat#: 112-605-003; RRID:AB_2338393IHC (1:200)
AntibodyGoat polyclonal anti-rabbit Alexa Fluor 647InvitrogenCat#: A21244; RRID:AB_2535812IHC (1:400)
AntibodyGoat polyclonal anti-HRP Alexa Fluor 488Jackson Immunoresearch LaboratoriesCat#: 123-545-021; RRID:AB_2338965IHC (1:400)
AntibodyGoat polyclonal anti-HRP Cy3Jackson Immunoresearch LaboratoriesCat#: 123-165-021; RRID:AB_2338959IHC (1:400)
Recombinant DNA reagentPlasmid: UAS-2xFlag-Imp α3This paper
Recombinant DNA reagentPlasmid: UAS-V5-Imp β1This paper
Recombinant DNA reagentPlasmid: UAS-CalpA-2xMycThis paper
Chemical compound, drugAll-trans-retinal (ATR) powderSigma-AldrichCat#: R2500; CAS: 116-31-41 mM
Software, algorithmZenZeissRRID:SCR_013672
Software, algorithmImageJNIHRRID:SCR_003070
Software, algorithmImageJ Ratio Plus (plug in)NIHPMID:22051797
Software, algorithmGraphPad PrismGraphPad SoftwareRRID:SCR_002798
Software, algorithmEthoVision XTNoldus Information TechnologyRRID:SCR_000441
Software, algorithmAdobe photoshopAdobeRRID:SCR_014199
OtherFlouro-BoxNeo ScienceFLB-001B

Drosophila melanogaster

Request a detailed protocol

Fly stocks used were as follows: w1118, D42-Gal4, TH-Gal4, repo-Gal4, GMR-gal4, UAS-mCD8-RFP, UAS-CD4-tdTom, Itprka1091/+, Itprsv35/+, 20XUAS-ChR2.T159C-HA, UAS-ChR2.S, RyR16/+, UAS-NachBac, UAS-R-GECO1-IR1,UAS-R-GECO1.L-IR2, MJDtr-78Q(s), elav-Gal4, UAS-Cam RNAi, UAS-CanA-14F RNAi, UAS-CanB RNAi, UAS-CaMKI RNAi, UAS-Pka-C1 RNAi, UAS-Pkc53E RNAi, UAS-CalpA RNAi (Ch.2), UAS-CalpA RNAi (Ch.3), UAS-CalpB RNAi, UAS-NFAT RNAi, UAS-nej RNAi, UAS-CrebB RNAi, UAS-Imp α1 RNAi, UAS-Imp α2 RNAi, UAS-Imp α3 RNAi, UAS-Imp β1 RNAi, UAS-Imp 7 RNAi, UAS-Imp β11 RNAi, UAS-Tnpo RNAi, UAS-Tnpo-SR RNAi, UAS-Ran RNAi, UAS-Ntf-2 RNAi, UAS-Hrb87F RNAi, UAS-HNPNPC RNAi, UAS-glo RNAi, UAS-Syp RNAi, Df(2R)BSC26, UAS-Luciferase, UAS-poly-PR.PO-100, and UAS-poly-GR.PO-100 were obtained from the Bloomington Drosophila Stock Center (BDSC). UAS-SERCA RNAi, UAS-Itpr RNAi, UAS-RyR RNAi, UAS-CaMKII RNAi, UAS-Imp α3 RNAi, UAS-RanGAP RNAi, UAS-Rcc1 RNAi, UAS-Hrb98DE RNAi, UAS-Hrb27C RNAi, UAS-HNRNPU1 RNAi, UAS-Sm RNAi, UAS-CalpA RNAi and 40DUAS were obtained from the Vienna Drosophila Resource Center (VDRC). UAS-TBPH-Flag-HA was obtained from the Bangalore Fly Resource Center. ppk1a-Gal4 (Han et al., 2011) was a gift from Yuh Nung Jan (UCSF). UAS-tdTomato P2A GCaMP5G (Daniels et al., 2014) was a gift from Barry Ganetzky (University of Wisconsin-Madison). UAS-3xMyc-RFP-TDP-43 was a gift from Brian D. McCabe (EPFL). UAS-Flag-TDP-43 and UAS-Flag-TDP-43-ΔNLS (Miguel et al., 2011) were gifts from Magalie Lecourtois (University of Rouen). UAS-TDP-43 WT and UAS-TDP-43 G287S were gifts from Aaron Voigt (University Hospital, RWTH Aachen University). UAS-empty (Park et al., 2020) was used as a control in Drosophila eye experiment. All Flies were raised at 27°C and 60% humidity.

Generation of transgenic fly lines

Request a detailed protocol

UAS-2xFlag-Imp α3 and UAS-CalpA-2xMyc transgenes were generated by using the LD13917 (Flybase ID: FBcl0163088) and LD22862 (Flybase ID: FBcl0178847) clones obtained from the Drosophila Genomics Resource Center (DGRC), respectively. UAS-V5-Imp β1 transgene was synthesized by Genscript (USA). All these transgenes were subcloned into pACU2 vector, and the transgenic fly lines were generated by Bestgene Inc (USA).

Immunohistochemistry

Request a detailed protocol

Larvae (120 hr AEL), pupae (18 hr APF), and adult flies (10d adult and 40d adult) were dissected in 1x Phosphate Buffered Saline (PBS) to obtain fillet or brain samples for immunohistochemical analyses. Obtained samples were fixed in 4% Paraformaldehyde for 20 min, washed in 0.3% PBST (Triton-X100 0.3% in PBS), and blocked in blocking buffer (5% Normal donkey serum or normal goat serum in 0.3% PBST) for 45 min at room temperature. Samples were then incubated with the following primary antibodies for overnight at 4°C: mouse anti-Flag (1F6, Wako; 1:400 dilution), rat anti-HA (3F10, Roche; 1:200 dilution), rabbit anti-TBPH (1:100 dilution) (Lin et al., 2011), and goat anti-HRP Alexa Fluor 488 (Jackson Immunoresearch Laboratories; 1:400 dilution) antibodies. The next day, samples were washed for 10 min (repeated three times) in 0.3% PBST and incubated with the following secondary antibodies for 4 hr: goat anti-mouse Alexa Fluor 647 (Invitrogen; 1:400 dilution), goat anti-rat Alexa Fluor 647 (Jackson Immunoresearch Laboratories; 1:200 dilution), and goat anti-rabbit Alexa Fluor 647 (Invitrogen; 1:400 dilution) antibodies. Samples were then rinsed with 0.3% PBST for 10 min (repeated three times) and mounted with 70% glycerol in phosphate buffered saline (PBG) for imaging.

Microscope image acquisition

Request a detailed protocol

All images were acquired using LSM 780, 800 (Zeiss) confocal microscope and Zen (Zeiss) software. All images of samples after immunohistochemistry experiments were taken at 200x and 400x magnifications using 20x and 40x objective lens, respectively. Images of the C4da sensory neurons were obtained from the abdominal segments A5-A6, where anterior is to the left and dorsal is up. Retinal images were obtained using Leica SP5. One-day-old adult fly eyes (left eyes only) were taken at 160x magnification immediately upon dissection.

The ratiometric calcium imaging and analysis

Request a detailed protocol

For ratiometric calcium imaging of C4da neurons in larval (120 hr AEL) and pupal (18 hr APF) stages, genetically encoded calcium indicator (GCaMP) and red fluorescent proteins, tdTomato (tdTom), were co-expressed in C4da neurons using P2A system (Daniels et al., 2014). The pseudo-colored images reflecting relative GCaMP level to tdTom level were generated by ImageJ Ratio plus. The mean pixel intensity of GCaMP/tdTom ratio was then measured using ImageJ to determine relative calcium levels, as previously described (Kardash et al., 2011).

Optogenetic stimulation

Request a detailed protocol

Larvae expressing channelrhodopsin in C4da neurons were used for optogenetic experiments (behavioral assay and calcium imaging). Larvae were raised under constant darkness at 27°C and 60% humidity on standard media containing 1 mM ATR (Sigma-Aldrich) and collected at 5 days AEL. ATR inhibits the closed state of cyclic nucleotide–gated channels, including channelrhodopsin: ATR is needed to keep the channels open upon stimulation with blue light. Optogenetic stimulation (470 nm) was achieved by Flouro-Box (FLB-001B). Illumination duration and frequency (denoted conditions in Figure 2G and Figure 2—figure supplement 1H) were controlled manually. Both control and experimental groups were placed in the box for illumination, but control groups were prevented from light exposure by covering the vials with aluminum foil. Optogenetic stimulation was performed in a room temperature of 25°C. The validity of optogenetic stimulation and concomitant calcium uptake of C4da neurons was confirmed by both live imaging of calcium indicator RGECO1 and monitoring nociceptive rolling behavior (Kaneko et al., 2017).

Fluorescence recovery after photobleaching (FRAP) experiment and analysis

Request a detailed protocol

FRAP experiment was performed by using Zeiss confocal microscope (LSM800). The control and experimental larvae were fed food without and with ATR, respectively. The optogenetic stimulation protocol from Figure 2—figure supplement 1H was applied to the larvae prior to FRAP. Nuclear area was selected as a region of interest (ROI), and cytoplasmic and extracellular areas of the cell were selected as reference and background, respectively, for normalization. Three pre-bleach images were obtained, and then photobleaching of the ROI was performed with 100% power of DPSS laser (561 nm laser) for three iterations. Images for fluorescence recovery were taken every 2 s during 5 min. For quantitative analysis, first, the mean intensity values of background were subtracted from those of ROI in obtained images. Then, these subtracted values were normalized to the fluorescence intensity of the reference. The normalized values were plotted for comparison, and best-fit curve was applied to the graph by using non-linear regression.

Quantitative analysis of dendrites

Request a detailed protocol

All images of dendrites were subjected to skeletonization using ImageJ for subsequent analyses of dendritic length and number of branch points. Sholl analysis protocol was adapted from a previous study (Yadav et al., 2019).

Larval motility assay and analysis

Request a detailed protocol

The wandering larvae (120 hr AEL) expressing denoted transgenes in motor neurons using the D42-Gal4 driver were used for motility assays. Prior to the assay, individual larva was gently washed in 1x PBS, then briefly placed in a 90 mm Petri dish containing 25 ml of 3% agar. The larva was then placed in another identical Petri dish inside a dark box equipped with indirect lighting. For each genotype, the time for larvae (n ≥ 23 per genotype) to reach the edge of the Petri dish or for up to 60 s was recorded. Recording only started after larva’s first sign of forward movement. These steps were applied to all genotypes tested.

To analyze the motility assay, EthoVision XT (13 version; Noldus Information Technology) video tracking system was used (Noldus et al., 2001). Residence probability until reaching the edge of the dish (up to 60 s) was shown as heat map (the color represented the amount of resident time; Red: large, Blue: small). Total distance travelled by larvae during 10 s was analyzed.

Western blot

Request a detailed protocol

Fly head samples were prepared in a lysis buffer solution (50 mM Tris-buffered saline (Tris-HCL) pH 7.5, 150 mM NaCl, 1% Triton X100) with protease inhibitor cocktail (Thermo Scientific, #87786; 1:100). Samples were centrifuged for 15 min at 13,300 rpm and the supernatants were collected into new tubes. Subsequently, their protein amount was measured using Bradford protein assay. Quantified proteins were mixed with a solution containing 9:1 ratio of Laemmli buffer (Bio-Rad, #161–0747) to 2-mercaptoethanol (BIOSESANG, #60-24-2) and were boiled at 95°C for 5 min. Samples were then loaded onto Mini-PROTEAN TGX Stain-Free, 4–15% gel (#BR456-8083, Bio-Rad). Protein transfer to the membrane (PVDF) was followed by an incubation in 5% skim milk diluted in 1% TBST (blocking buffer) for 1 hr at RT. Then they were incubated with primary antibodies overnight at 4°C. The follow primary antibodies were used: Rabbit anti-TBPH (from Dr. C.-K. James Shen) (1:5000), Rat anti-elav (DSHB 7E8A10) (1:200,000). After washing, the membranes were then incubated for 1 hr at RT with the corresponding secondary antibodies: Goat anti-rat IgG-HRP (Santa Cruz, sc-2006) (1:100,000) and Goat anti-rabbit IgG HRP (Santa Cruz, sc-3837) (1:5000). Finally, after washing five times in 1% TBST at RT, the membranes were incubated with ECL solution prior to detection using ChemiDocTM XRS+.

Quantification and statistical analysis

Request a detailed protocol

To calculate the cytoplasm-to-nucleus (Cyt/Nuc) ratios of immunostained proteins (TBPH-Flag-HA, endogenous TBPH, 3xMyc-RFP-TDP-43, and 2xFlag-Imp α3), the mean pixel intensities of them in the nucleus and cytoplasm were measured using ImageJ (NIH) and Adobe photoshop (Adobe).

Statistical analysis was performed using GraphPad Prism (GraphPad Software), with Student’s t-test and one-way ANOVA followed by Tukey’s post hoc analysis. In all figures, N.S., *, **, ***, and **** represent p>0.05, p<0.05, p<0.01, p<1.0×10−3, and p<1.0×10−4 respectively. Error bars are standard errors of the mean (SEM).

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

References

    1. Mason DA
    2. Mathe E
    3. Fleming RJ
    4. Goldfarb DS
    (2003)
    The Drosophila melanogaster importin alpha3 locus encodes an essential gene required for the development of both larval and adult tissues
    Genetics 165:1943–1958.

Decision letter

  1. Jiwon Shim
    Reviewing Editor; Hanyang University, Republic of Korea
  2. K VijayRaghavan
    Senior Editor; National Centre for Biological Sciences, Tata Institute of Fundamental Research, India
  3. Randal S Tibbetts
    Reviewer; University of Wisconsin School of Medicine and Public Health, United States

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Acceptance summary:

Cytoplasmic accumulation of TDP-43 is the most prominent cellular characteristic for amyotrophic lateral sclerosis (ALS). However, how TDP-43 shuttles between the nucleus and cytoplasm and how TDP-43 remains in the cytoplasm during pathological conditions have not been thoroughly investigated. In this study, Lee and colleagues discovered that TBPH, a TDP-43 orthologue in Drosophila, naturally translocates between the nucleus and cytoplasm during development and identified the calcium-Calpain-A-Importin α3 as a regulatory pathway for the TBPH movement. These findings provide new insights into the cellular behavior of TDP-43 and raise a possibility that dynamic control of TDP-43 translocation can contribute to excessive TDP-43 accumulation in ALS.

Decision letter after peer review:

Thank you for submitting your article "Cytosolic calcium regulates cytoplasmic accumulation of TDP-43 through Calpain-A and Importin α3" for consideration by eLife. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by K VijayRaghavan as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Randal S Tibbetts (Reviewer #3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in eLife but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.

Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in eLife, either of which would be linked to the original paper.

Summary:

In this manuscript, Lee and colleagues investigated molecular mechanisms underlying the nucleocytoplasmic transport of TDP-43 in Drosophila sensory neurons and identified cytosolic calcium-CalpainA-Importin a3 as a key regulatory axis for the transient localization of TDP-43. The authors first confirmed that the localization of TDP-43 changes over larval-pupal-adult development whose pattern can be significantly altered by changing the level of cytosolic calcium. Moreover, the authors took on to screen genetic modifiers of the TDP-43 shuttling and found two key genes, CalpainA and Imp-α3, in the process. Alterations in the TDP-43 localization in C4 neurons largely inhibit the dendritic arborization, which is partially rescued by knocking down Impa3. Further, the authors verified the similar phenomenon in the C9orf72 ALS model, extending their findings to the clinical perspective and suggest the Ca2+-CalpainA-Impa3 axis as a potential therapeutic target for ALS.

All the reviewers found the work interesting and well-executed, and most of the conclusions are convincing. While the developmental studies are clearly presented, the part where the authors describe a link to human pathomechanism leaves room to improve presented data and overall novelty. Several revisions were requested, which may require additional experiments.

Essential revisions:

1) Improve the quality of Figure 7. Images in Figure 7A can be better presented. Merged VNC images do not provide precise information as to what the authors want to show. Selected motor neurons in yellow insets are in variable locations and do not seem to indicate identical neurons. Although quantified, one or more motor neurons in the same position should be presented.

2) Show developmental or stage-specific expressions of TBPH, and discuss their biological meanings. What is TBPH localization at intermediate stages of development prior to pupation? Amongst many developmental stages, the authors focused on 120h AEL and 18h APF without providing backgrounds or rationales. Why are the stages critical for the experiment?

3) Provide additional descriptions of the optogenetic experiments; especially two different exposure times in Figure 2/Figure 2—figure supplement 1. An additional description of the optogenetic approach is needed in the text.

4) Confirm whether C4da specific knockdown of calcium modulators (e.g. Iptr) leads to the same TBPH translocation and whether it can rescue dendritic arborization phenotypes caused by TBPH. It would seem important to show that Ca2+-handling mutants (Iptr mutant or RNAi background) also impact TBPH toxicity using dendritic arborization, larval mobility, or other assays.

5) The authors claim in Figure 6 that nuclear TBPH is toxic while they conclude that increasing nuclear TBPH is protective of C9 DPR in Figure 7. The authors need to explain these contradicting explanations and provide additional data to support the claims. All experiments were carried out using fly TBPH. While this approach holds advantages, it would be important to compare wild-type and ALS-mutant human TDP-43 proteins for their nucleocytosolic shuttling dynamics in a subset of the developmental and Ca2-mobilization studies.

https://doi.org/10.7554/eLife.60132.sa1

Author response

Essential revisions:

1) Improve the quality of Figure 7. Images in Figure 7A can be better presented. Merged VNC images do not provide precise information as to what the authors want to show. Selected motor neurons in yellow insets are in variable locations and do not seem to indicate identical neurons. Although quantified, one or more motor neurons in the same position should be presented.

Based on the reviewers’ suggestion, we modified how we present the images in Figure 7A. To provide a more precise information, we enlarged the merged VNC images. This allowed us to mark more precisely some of the neurons that we quantified. For the ease of comparison, we have selected neurons from the same location (A3-A5) in the VNC and presented them in Figure 7A as representative images.

2) Show developmental or stage-specific expressions of TBPH, and discuss their biological meanings. What is TBPH localization at intermediate stages of development prior to pupation? Amongst many developmental stages, the authors focused on 120h AEL and 18h APF without providing backgrounds or rationales. Why are the stages critical for the experiment?

In Figure 1—figure supplement 1, we showed that the localization of endogenous TBPH shifts from the cytoplasm in larval C4da neurons to the nucleus in pupal C4da neurons. By comparing the level of immunostained endogenous TBPH between larval and pupal C4da neurons, we can speculate that the expression of TBPH does not change much between the two stages. However, we need to be extra cautious when comparing TBPH expression based on the immunostaining data, because the efficiency of antibody staining likely differs between the two stages. Furthermore, the difference in C4da neuron size between the two stages may create complications when analyzing the expression level via immunostaining. Endogenous TBPH staining also lead to the detection of TBPH in the tissues around C4da neurons including epithelia, muscles, and glia, all of which obstruct our ability to detect TBPH in C4da neuronal dendrites. Doing a western blot will require isolation of C4da neurons due to the cell-type specific effects observed in our study. Because of the small number of C4da neurons per larva, it will take a herculean effort to collect enough samples for a western blot. Thus, the technical difficulties greatly limit our ability to compare developmental or stage-specific expressions of TBPH with precision.

To test whether developmental processes might affect TBPH localization, we thought that it was important to examine TBPH localization at three major stages of a fly—larva, pupa, and adult (sub-divided into early and late adult)—because the cellular condition changes dramatically from one stage to the next, which may affect TBPH localization. This hypothesis was confirmed by the change in the intracellular calcium level between larval and pupal C4da neurons, which led to the altered localization of TBPH in pupa. As recommended by the reviewer, we also examined the localization pattern of TBPH at the prepupa stage (0h APF), the intermediate stage between larva and pupa (see revised Figure 1C and D). Our results showed an intermediate TBPH localization pattern at the intermediate stage, suggesting that TBPH undergoes a localization transition from the cytoplasm into the nucleus in prepupa. Although we initially examined three major developmental stages of a fly in Figure 1, we decided to focus more specifically on larval (120h AEL) and pupal (18h APF) stages for a couple of reasons. First, larval C4da neurons showed the most dramatic cytoplasmic localization of TBPH among all the stages examined, thus rendering this stage an ideal timepoint at which to examine the mechanisms underlying the cytoplasmic localization of TBPH. 18h APF—but not 40d adult—was chosen as the preferred stage to model nuclear localization of TBPH because it is temporally closer to the larval stage than 40d adult stage is. Choosing these two consecutive stages for further studies in our manuscript helped us to save time as we did not need to wait 40d when probing mechanisms underlying the stage-dependent nucleocytoplasmic translocation of TBPH.

What biological meaning might underlie the observed stage-specific alteration of the TBPH expression pattern? This stage-specific alteration can be speculated as one way by which the neurons regulate TBPH function. For instance, we reported that TBPH localizes in the cytoplasm of C4da neurons at the larval stage, unlike in other cell types (motor and DA neurons and glial cells). Nuclear TBPH in larval C4da neurons induced a significant dendrite toxicity compared to cytoplasmic TBPH. These data suggest that limiting nuclear function of TBPH in C4da neurons at the larval stage is needed to maintain neuronal health. Why does TBPH then translocate from the cytoplasm to the nucleus at the pupal stage? Previously, loss of TBPH function was shown to increase Map205 expression, resulting in cytoplasmic mis-localization of ecdysone receptor-A (EcR-A), which is expressed predominantly during the late pupa stage (Vanden Broeck et al., 2013). According to this result, TBPH may translocate into the nucleus during the pupal stage to regulate Map205 expression and nuclear localization of EcR-A, which is important for proper metamorphosis. Of note, loss of liver X receptor β (LXRβ), a mammalian ortholog of EcR, results in motor neuron degeneration (Andersson et al., 2005; Bigini et al., 2010) and LXRβ physically interacts with TDP-43 (Vanden Broeck et al., 2013). Taken together, neurons may control dynamically the nucleocytoplasmic translocation of TDP-43 upon specific cellular demands such as regulation of EcR-A localization during metamorphosis.

The newly added results and the discussion on the potential biological meaning of the differences in TBPH localization between stages have been incorporated into our revised manuscript.

Results:

“The endogenous TBPH expression level in C4da neurons between the two stages seemed comparable based on the immunostaining data”.

“TBPH was localized to both the cytoplasm and the nucleus in an intermediate stage (0h APF) between larva and pupa (Figure 1C), suggesting that TBPH may begin its nuclear entry at this stage. […] Quantitative comparisons revealed that Cyt/Nuc ratios between pairs of consecutive developmental stages (AEL-0h APF, 0h-18h APF, 18h APF-early adult, and early-late adult) were significantly different (Figure 1D)”.

Discussion

“We reported in this study that TBPH localization shifts from the cytoplasm (at larval period) to the nucleus (at pupal period), but for what reason TBPH translocates into the nucleus during the pupal stage remains unknown. […] Taken together, it seems possible that neurons dynamically control the nucleocytoplasmic translocation of TDP-43 upon specific cellular demands such as regulation of LXRβ signaling associated with ALS pathogenesis”.

3) Provide additional descriptions of the optogenetic experiments; especially two different exposure times in Figure 2/Figure 2—figure supplement 1. An additional description of the optogenetic approach is needed in the text.

In the original manuscript, we showed two separate optogenetic data (one in Figure 2G-I and another in Figure 2—figure supplement 1H-J) using two different experimental protocols with distinct exposure times. As suggested by the reviewer, this difference in protocols needs to be better described and justified. However, a better solution might be to apply the same protocol for both experiments. We thus performed the experiments for Figure 2—figure supplement 1 with the same protocol used for Figure 2G-I and replaced the previous results with the new ones in the revised manuscript. Furthermore, as requested, we have now incorporated additional descriptions of the optogenetic experiments. We added several details such as channelrhodopsin expression and the feeding of all trans-retinal (ATR) in larvae prior to the optogenetic experiment. We hope that the description of the optogenetic experiments are sufficiently clear for the reviewers and the general readership. The excerpt describing the optogenetic experiments from Figure 2/Figure 2—figure supplement 1 in the revised manuscript is provided below:

Results

“To reduce the possibility of activating compensatory mechanism from chronically increasing cytosolic calcium, we decided to increase intracellular calcium level in larval C4da neurons using an optogenetics technique. […] When we decreased the total amount of larval exposure to blue light to just 5 min, the Cyt/Nuc ratio of RFP-TDP-43 did not change at any of the time points (1 min, 30 min, 60 min, 90 min, and 120 min) imaged after the exposure (data not shown), suggesting that five minutes of increased cytosolic calcium is not enough to alter RFP-TDP-43 localization”.

4) Confirm whether C4da specific knockdown of calcium modulators (e.g. Iptr) leads to the same TBPH translocation and whether it can rescue dendritic arborization phenotypes caused by TBPH. It would seem important to show that Ca2+-handling mutants (Iptr mutant or RNAi background) also impact TBPH toxicity using dendritic arborization, larval mobility, or other assays.

We thank the reviewers for an invaluable experimental suggestion. A knockdown of Itpr or another Itpr mutant (Itprsv35/+) showed a significantly higher amount of TBPH in the cytoplasm than in the nucleus of pupal C4da neurons, resulting in an increased Cyt/Nuc ratio compared to the controls (Figure 2—figure supplement 1A and B). These data are consistent with the Itprka1091/+ pupae data (Figure 2C and D) from our original manuscript.

Next, we tested whether Ca2+-handling mutants or knockdowns also impact TBPH-induced alteration in dendritic arborization pattern. We have shown in Figure 6 of the original manuscript that nuclear TBPH is toxic and reduces total dendritic length and the number of dendritic branch points in C4da neurons. In the revised manuscript, we show that SERCA knockdown, which promotes nuclear translocation of overexpressed TBPH, exacerbated the TBPH-induced toxicity by reducing the total dendritic length and the number of dendritic branch points in larval C4da neurons (Figure 6E-G). In addition, Itpr knockdown (Figure 6E-G) or mutants (Figure 6—figure supplement 1A-C), which inhibit nuclear translocation of overexpressed TBPH, mitigated TBPH-induced dendrite toxicity by increasing the total dendritic length and the number of dendritic branch points. Together, these data suggest that intracellular calcium not only regulates the nucleocytoplasmic localization of TBPH, but also modulates TBPH-mediated dendritic defects. These additional results are now incorporated into the revised manuscript.

Results

“Similar results were found using another Itpr mutant (Itprsv35/+) and Itpr RNAi (Figure 2—figure supplement 1A and B)”.

“Consistently, manipulating cytosolic calcium to alter the localization of overexpressed TBPH also led to similar dendritic phenotypes. SERCA knockdown, which promotes nuclear translocation of overexpressed TBPH, decreased the total dendritic length (Figure 6E and F) and the number of dendritic branch points (Figures 6E and G) in larval C4da neurons. Itpr knockdown (Figure 6E and G) or mutants (Figure 6—figure supplement 1A-1C), which inhibit nuclear translocation of overexpressed TBPH, increased the total dendritic length and the number of dendritic branch points.”

5) The authors claim in Figure 6 that nuclear TBPH is toxic while they conclude that increasing nuclear TBPH is protective of C9 DPR in Figure 7. The authors need to explain these contradicting explanations and provide additional data to support the claims. All experiments were carried out using fly TBPH. While this approach holds advantages, it would be important to compare wild-type and ALS-mutant human TDP-43 proteins for their nucleocytosolic shuttling dynamics in a subset of the developmental and Ca2-mobilization studies.

We claimed that nuclear TBPH is toxic in C4da neurons (Figure 6) because the original location of TBPH is mostly cytoplasmic in C4da neurons. However, we claimed that cytoplasmic TBPH is toxic in motor neurons because the original location of TBPH is nuclear in those neurons. The hypothesis that underlies these claims is that if the localization of TBPH is altered from its original cell-type specific localization, then that would induce toxicity. Indeed, C4da neurons overexpressing TBPH in the cytoplasm showed considerably less dendritic defects than those overexpressing it in the nucleus (Figure 6). In motor neurons, we showed that SERCA knockdown reduced cytoplasmic mis-localization of TBPH and mitigated the locomotion defect of GR100-expressing larvae, indicating a correlation between the cytoplasmic TBPH in motor neurons and the locomotion defect (Figure 7). In the revised manuscript, we further tested our hypothesis in another cell type, the retina. First, we examined the localization of endogenous TBPH in the neurons of eye imaginal disc in 3rd instar larvae and showed that it is mostly nuclear. TDP-43 WT expressed in these cells was shown to be mostly confined to the nucleus, whereas TDP-43-∆NLS was observed mostly in the cytoplasm. At 1-day post eclosion, we noticed no degenerative phenotypes in flies expressing TDP-43 WT. On the other hand, TDP-43-∆NLS expression induced a significant retinal degeneration. These results support our hypothesis that altered localization of TBPH/TDP-43 from its original cell-type specific localization is toxic. These additional results and the corresponding text are now incorporated into the revised manuscript.

In our original manuscript, most of the experiments on nucleocytoplasmic shuttling have been carried out using Drosophila TDP-43 (TBPH). As suggested by the reviewers, we compared WT and ALS-mutant human TDP-43 for their nucleocytoplasmic shuttling dynamics in a subset of the developmental and calcium-mobilization studies. First, we expressed human TDP-43 WT and ALS-mutant TDP-43 G287S in C4da neurons and then examined their localization patterns along the development from larva to pupa. As expected, the localization of TDP-43 WT significantly changed from the cytoplasm at the larval stage (120h after egg laying; 120h AEL) to the nucleus at the pupal stage (18h after puparium formation; 18h APF). The localization of TDP-43 G287S also shifted from the cytoplasm to the nucleus, albeit less so compared to TDP-43 WT. Notably, the net change in the Cyt/Nuc ratio from larvae to pupae decreased more for TDP-43 than for TDP-43 G287S. When we decreased cytosolic calcium via ryanodine receptor (RyR) knockdown in pupae, the Cyt/Nuc ratio of TDP-43 WT increased significantly. The localization of TDP-43 G287S also shifted back towards the cytoplasm (Cyt/Nuc ratio of ~0.5 to ~0.8), but the magnitude of the shift was again smaller than that of TDP-43 WT. These data suggest that the nucleocytoplasmic transport process of TDP-43 G287S is less sensitive than that of TDP-43 WT to the changes in development and cytosolic calcium. These additional results are now incorporated into the revised manuscript.

Results

“Taken together, these results support the notion that expression of TBPH/TDP-43 in a location different from its original cell-type specific location is toxic, whether it is a mis-localization from the nucleus to the cytoplasm as observed in Drosophila retina (Figure 6—figure supplement 3A-C) or from the cytoplasm to the nucleus as in C4da neurons”

“Next, we examined the subcellular localization of ALS-linked mutant TDP-43 G287S (Voigt et al., 2010) and tested whether developmental process or calcium can alter its localization. As expected, the localization of TDP-43 WT significantly changed from the cytoplasm in larvae to the nucleus in pupae (Figure 2—figure supplement 2A and B). […] These data suggest that TDP-43 G287S is less sensitive than TDP-43 WT to the changes in development and cytosolic calcium in mediating nucleocytoplasmic transport”.

https://doi.org/10.7554/eLife.60132.sa2

Article and author information

Author details

  1. Jeong Hyang Park

    1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
    2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
    Contribution
    Conceptualization, Resources, Formal analysis, Investigation, Visualization, Writing - original draft, Writing - review and editing
    Contributed equally with
    Chang Geon Chung
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7392-8366
  2. Chang Geon Chung

    1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
    2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
    Contribution
    Conceptualization, Resources, Formal analysis, Investigation, Visualization, Writing - original draft, Writing - review and editing
    Contributed equally with
    Jeong Hyang Park
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8155-4926
  3. Sung Soon Park

    1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
    2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
    Contribution
    Formal analysis, Investigation, Visualization, Writing - original draft
    Competing interests
    No competing interests declared
  4. Davin Lee

    1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
    2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
    Contribution
    Formal analysis, Investigation, Visualization, Writing - original draft
    Competing interests
    No competing interests declared
  5. Kyung Min Kim

    1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
    2. School of Biological Sciences, Seoul National University, Seoul, Republic of Korea
    Contribution
    Formal analysis, Investigation, Visualization
    Competing interests
    No competing interests declared
  6. Yeonjin Jeong

    1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
    2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
    Contribution
    Formal analysis, Visualization
    Competing interests
    No competing interests declared
  7. Eun Seon Kim

    1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
    2. Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea
    Contribution
    Investigation
    Competing interests
    No competing interests declared
  8. Jae Ho Cho

    1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
    2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
    Contribution
    Formal analysis
    Competing interests
    No competing interests declared
  9. Yu-Mi Jeon

    Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea
    Contribution
    Investigation
    Competing interests
    No competing interests declared
  10. C-K James Shen

    Taipei Medical University/Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan
    Contribution
    Resources
    Competing interests
    No competing interests declared
  11. Hyung-Jun Kim

    Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea
    Contribution
    Investigation
    Competing interests
    No competing interests declared
  12. Daehee Hwang

    School of Biological Sciences, Seoul National University, Seoul, Republic of Korea
    Contribution
    Conceptualization, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing
    For correspondence
    daehee@snu.ac.kr
    Competing interests
    No competing interests declared
  13. Sung Bae Lee

    1. Department of Brain & Cognitive Sciences, DGIST, Daegu, Republic of Korea
    2. Protein dynamics-based proteotoxicity control laboratory, Basic research lab, DGIST, Daegu, Republic of Korea
    3. Dementia research group, Korea Brain Research Institute (KBRI), Daegu, Republic of Korea
    Contribution
    Conceptualization, Resources, Supervision, Funding acquisition, Writing - original draft, Writing - review and editing
    For correspondence
    sblee@dgist.ac.kr
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8980-6769

Funding

Ministry of science and ICT (2018R1A2B6001607)

  • Sung Bae Lee

Ministry of science and ICT (2019R1A4A1024278)

  • Sung Bae Lee

Korea Research Institute of Standards and Science (KRISS-2019-GP2019-0018)

  • Sung Bae Lee

Ministry of Science and ICT (20-BR-04-02)

  • Sung Bae Lee

Ministry of Science and ICT (IBS-R013-A1)

  • Daehee Hwang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We thank the Bloomington Drosophila Stock Center, the Vienna Drosophila Resource Center and Bangalore Fly Resource Center for fly stocks. We thank Yuh Nung Jan (UCSF), Barry Ganetzky (University of Wisconsin-Madison), Aaron Voigt (University Hospital, RWTH Aachen University), Brian D McCabe (EPFL) and Magalie Lecourtois (University of Rouen) for providing precious resources. This work was supported by Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Science and Information and Communications Technology (ICT) (2018R1A2B6001607, 2019R1A4A1024278); the Development of Platform Technology for Innovative Medical Measurements Program from the Korea Research Institute of Standards and Science Grant (KRISS-2019-GP2019-0018); KBRI basic research program through Korea Brain Research Institute funded by Ministry of Science and ICT (20-BR-04–02) (to SB Lee); and Institute for Basic Science Grant (IBS-R013-A1) funded by the Ministry of Science and ICT (to D Hwang).

Senior Editor

  1. K VijayRaghavan, National Centre for Biological Sciences, Tata Institute of Fundamental Research, India

Reviewing Editor

  1. Jiwon Shim, Hanyang University, Republic of Korea

Reviewer

  1. Randal S Tibbetts, University of Wisconsin School of Medicine and Public Health, United States

Publication history

  1. Received: June 17, 2020
  2. Accepted: December 9, 2020
  3. Accepted Manuscript published: December 11, 2020 (version 1)
  4. Version of Record published: December 18, 2020 (version 2)
  5. Version of Record updated: December 30, 2020 (version 3)

Copyright

© 2020, Park et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,633
    Page views
  • 322
    Downloads
  • 2
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

Further reading

    1. Genetics and Genomics
    2. Neuroscience
    Li Hou et al.
    Research Article Updated

    Long-term flight depends heavily on intensive energy metabolism in animals; however, the neuroendocrine mechanisms underlying efficient substrate utilization remain elusive. Here, we report that the adipokinetic hormone/corazonin-related peptide (ACP) can facilitate muscle lipid utilization in a famous long-term migratory flighting species, Locusta migratoria. By peptidomic analysis and RNAi screening, we identified brain-derived ACP as a key flight-related neuropeptide. ACP gene expression increased notably upon sustained flight. CRISPR/Cas9-mediated knockout of ACP gene and ACP receptor gene (ACPR) significantly abated prolonged flight of locusts. Transcriptomic and metabolomic analyses further revealed that genes and metabolites involved in fatty acid transport and oxidation were notably downregulated in the flight muscle of ACP mutants. Finally, we demonstrated that a fatty-acid-binding protein (FABP) mediated the effects of ACP in regulating muscle lipid metabolism during long-term flight in locusts. Our results elucidated a previously undescribed neuroendocrine mechanism underlying efficient energy utilization associated with long-term flight.

    1. Neuroscience
    Krishna N Badhiwala et al.
    Research Article

    Hydra vulgaris is an emerging model organism for neuroscience due to its small size, transparency, genetic tractability, and regenerative nervous system; however, fundamental properties of its sensorimotor behaviors remain unknown. Here, we use microfluidic devices combined with fluorescent calcium imaging and surgical resectioning to study how the diffuse nervous system coordinates Hydra's mechanosensory response. Mechanical stimuli cause animals to contract, and we find this response relies on at least two distinct networks of neurons in the oral and aboral regions of the animal. Different activity patterns arise in these networks depending on whether the animal is contracting spontaneously or contracting in response to mechanical stimulation. Together, these findings improve our understanding of how Hydra’s diffuse nervous system coordinates sensorimotor behaviors. These insights help reveal how sensory information is processed in an animal with a diffuse, radially symmetric neural architecture unlike the dense, bilaterally symmetric nervous systems found in most model organisms.